Gene Symbol | Gene ID | Gene Info |
---|---|---|
PLAGL1
|
ENSG00000118495.14 | PLAG1 like zinc finger 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr6_144292713_144292864 | PLAGL1 | 2673 | 0.370002 | -0.84 | 4.8e-03 | Click! |
chr6_144386506_144386657 | PLAGL1 | 846 | 0.683400 | 0.83 | 5.8e-03 | Click! |
chr6_144388201_144388461 | PLAGL1 | 2596 | 0.334402 | 0.81 | 8.2e-03 | Click! |
chr6_144328201_144328619 | PLAGL1 | 988 | 0.667029 | 0.78 | 1.3e-02 | Click! |
chr6_144376532_144376934 | PLAGL1 | 9002 | 0.247275 | 0.77 | 1.6e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr21_45576719_45576946 | 3.59 |
AP001055.1 |
|
16748 |
0.13 |
chr5_175956521_175957004 | 3.30 |
RNF44 |
ring finger protein 44 |
884 |
0.47 |
chr19_39369157_39369690 | 2.99 |
RINL |
Ras and Rab interactor-like |
504 |
0.57 |
chr11_2321744_2322272 | 2.46 |
C11orf21 |
chromosome 11 open reading frame 21 |
1135 |
0.3 |
chr20_37432775_37433181 | 2.44 |
PPP1R16B |
protein phosphatase 1, regulatory subunit 16B |
1370 |
0.43 |
chr11_2488116_2488649 | 2.43 |
KCNQ1 |
potassium voltage-gated channel, KQT-like subfamily, member 1 |
5265 |
0.19 |
chr3_52739214_52739466 | 2.40 |
SPCS1 |
signal peptidase complex subunit 1 homolog (S. cerevisiae) |
312 |
0.45 |
chr16_68109101_68109477 | 2.29 |
NFATC3 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3 |
9958 |
0.1 |
chr11_2322362_2322574 | 2.24 |
C11orf21 |
chromosome 11 open reading frame 21 |
675 |
0.42 |
chr11_2320203_2320640 | 2.16 |
C11orf21 |
chromosome 11 open reading frame 21 |
2722 |
0.17 |
chr17_19036587_19036921 | 2.15 |
GRAPL |
GRB2-related adaptor protein-like |
722 |
0.45 |
chr14_24837393_24837740 | 2.12 |
NFATC4 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4 |
19 |
0.94 |
chr16_57166733_57166910 | 2.12 |
CPNE2 |
copine II |
13710 |
0.14 |
chr22_50752388_50752886 | 2.09 |
XX-C283C717.1 |
|
423 |
0.69 |
chr7_99764513_99764874 | 2.09 |
GAL3ST4 |
galactose-3-O-sulfotransferase 4 |
160 |
0.86 |
chr1_204430993_204431895 | 2.08 |
PIK3C2B |
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 beta |
5030 |
0.21 |
chr21_45577023_45577427 | 2.06 |
AP001055.1 |
|
16355 |
0.13 |
chr14_73525713_73526043 | 2.05 |
RBM25 |
RNA binding motif protein 25 |
502 |
0.78 |
chr1_95699814_95699965 | 2.05 |
RWDD3 |
RWD domain containing 3 |
122 |
0.77 |
chr5_177665749_177666095 | 2.03 |
PHYKPL |
5-phosphohydroxy-L-lysine phospho-lyase |
6136 |
0.21 |
chr3_13024430_13024661 | 2.01 |
IQSEC1 |
IQ motif and Sec7 domain 1 |
3991 |
0.31 |
chr17_80259593_80259778 | 2.00 |
CD7 |
CD7 molecule |
15743 |
0.1 |
chr11_1873282_1874046 | 2.00 |
LSP1 |
lymphocyte-specific protein 1 |
536 |
0.61 |
chr12_132859595_132859799 | 1.95 |
RP13-895J2.3 |
|
5762 |
0.18 |
chr17_1084037_1084305 | 1.93 |
ABR |
active BCR-related |
1003 |
0.38 |
chr22_17597863_17598182 | 1.90 |
CECR6 |
cat eye syndrome chromosome region, candidate 6 |
4121 |
0.17 |
chr17_40827970_40828303 | 1.90 |
PLEKHH3 |
pleckstrin homology domain containing, family H (with MyTH4 domain) member 3 |
833 |
0.38 |
chr10_73494821_73495244 | 1.88 |
C10orf105 |
chromosome 10 open reading frame 105 |
2549 |
0.3 |
chr21_46332323_46332721 | 1.83 |
ITGB2 |
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
1147 |
0.33 |
chr6_33882815_33883519 | 1.82 |
ENSG00000221697 |
. |
84661 |
0.08 |
chr5_177543276_177543552 | 1.82 |
N4BP3 |
NEDD4 binding protein 3 |
2970 |
0.23 |
chr6_167460082_167460376 | 1.81 |
FGFR1OP |
FGFR1 oncogene partner |
47333 |
0.1 |
chr19_11564817_11564968 | 1.81 |
ENSG00000265149 |
. |
13199 |
0.08 |
chr1_54941539_54941789 | 1.80 |
ENSG00000265404 |
. |
28677 |
0.16 |
chr16_28304841_28305136 | 1.80 |
SBK1 |
SH3 domain binding kinase 1 |
1148 |
0.52 |
chr22_42695306_42695687 | 1.79 |
TCF20 |
transcription factor 20 (AR1) |
44126 |
0.14 |
chr7_2739159_2739434 | 1.79 |
AMZ1 |
archaelysin family metallopeptidase 1 |
11460 |
0.21 |
chr9_130330157_130330567 | 1.78 |
FAM129B |
family with sequence similarity 129, member B |
1005 |
0.52 |
chr16_88545798_88545998 | 1.77 |
ENSG00000263456 |
. |
10572 |
0.17 |
chr19_16488200_16488421 | 1.77 |
EPS15L1 |
epidermal growth factor receptor pathway substrate 15-like 1 |
15546 |
0.14 |
chr1_1148836_1149071 | 1.77 |
TNFRSF4 |
tumor necrosis factor receptor superfamily, member 4 |
559 |
0.53 |
chr11_1909959_1910419 | 1.76 |
C11orf89 |
chromosome 11 open reading frame 89 |
1895 |
0.19 |
chr17_76254387_76254694 | 1.76 |
TMEM235 |
transmembrane protein 235 |
26418 |
0.12 |
chr2_113931023_113931259 | 1.75 |
PSD4 |
pleckstrin and Sec7 domain containing 4 |
407 |
0.76 |
chr10_73495294_73495587 | 1.75 |
C10orf105 |
chromosome 10 open reading frame 105 |
2141 |
0.34 |
chr2_233185795_233185978 | 1.75 |
DIS3L2 |
DIS3 mitotic control homolog (S. cerevisiae)-like 2 |
12767 |
0.18 |
chr11_1911048_1911370 | 1.74 |
C11orf89 |
chromosome 11 open reading frame 89 |
875 |
0.42 |
chr16_50717313_50717932 | 1.73 |
SNX20 |
sorting nexin 20 |
2358 |
0.19 |
chr7_2739468_2739742 | 1.72 |
AMZ1 |
archaelysin family metallopeptidase 1 |
11769 |
0.21 |
chr1_2485967_2486421 | 1.72 |
TNFRSF14 |
tumor necrosis factor receptor superfamily, member 14 |
884 |
0.38 |
chr1_26861688_26862188 | 1.71 |
RPS6KA1 |
ribosomal protein S6 kinase, 90kDa, polypeptide 1 |
4119 |
0.17 |
chr15_91446650_91446801 | 1.70 |
MAN2A2 |
mannosidase, alpha, class 2A, member 2 |
249 |
0.84 |
chr16_88766525_88766822 | 1.70 |
RNF166 |
ring finger protein 166 |
209 |
0.83 |
chr11_67042287_67042439 | 1.70 |
ADRBK1 |
adrenergic, beta, receptor kinase 1 |
8411 |
0.11 |
chr11_67173204_67173355 | 1.69 |
TBC1D10C |
TBC1 domain family, member 10C |
1619 |
0.15 |
chr16_29675395_29675762 | 1.69 |
QPRT |
quinolinate phosphoribosyltransferase |
978 |
0.33 |
chr17_19035496_19035720 | 1.68 |
GRAPL |
GRB2-related adaptor protein-like |
242 |
0.84 |
chr20_62475797_62476005 | 1.68 |
AL158091.1 |
Protein LOC100509861 |
628 |
0.51 |
chr19_55765960_55766111 | 1.68 |
PPP6R1 |
protein phosphatase 6, regulatory subunit 1 |
1102 |
0.28 |
chr11_67178704_67178855 | 1.68 |
CARNS1 |
carnosine synthase 1 |
4370 |
0.08 |
chr5_176857919_176858519 | 1.65 |
GRK6 |
G protein-coupled receptor kinase 6 |
4364 |
0.11 |
chr20_23401674_23401825 | 1.65 |
NAPB |
N-ethylmaleimide-sensitive factor attachment protein, beta |
349 |
0.81 |
chr19_42702815_42703281 | 1.65 |
ENSG00000265122 |
. |
5818 |
0.1 |
chr17_79420586_79420890 | 1.64 |
ENSG00000266189 |
. |
2524 |
0.16 |
chr14_93081555_93081992 | 1.62 |
RIN3 |
Ras and Rab interactor 3 |
37073 |
0.2 |
chr1_43417564_43417791 | 1.62 |
SLC2A1 |
solute carrier family 2 (facilitated glucose transporter), member 1 |
6823 |
0.19 |
chr17_3818217_3818504 | 1.62 |
P2RX1 |
purinergic receptor P2X, ligand-gated ion channel, 1 |
1434 |
0.36 |
chr19_4083978_4084223 | 1.62 |
MAP2K2 |
mitogen-activated protein kinase kinase 2 |
16945 |
0.1 |
chr1_23810120_23810354 | 1.62 |
ASAP3 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain 3 |
434 |
0.83 |
chr19_42463079_42463289 | 1.62 |
RABAC1 |
Rab acceptor 1 (prenylated) |
118 |
0.95 |
chr5_98106280_98106431 | 1.62 |
RGMB |
repulsive guidance molecule family member b |
1356 |
0.43 |
chr22_38071514_38071665 | 1.62 |
LGALS1 |
lectin, galactoside-binding, soluble, 1 |
26 |
0.95 |
chr8_126518452_126518899 | 1.61 |
ENSG00000266452 |
. |
61868 |
0.13 |
chr2_96824462_96824613 | 1.61 |
DUSP2 |
dual specificity phosphatase 2 |
13358 |
0.14 |
chr20_55976055_55976264 | 1.60 |
RP4-800J21.3 |
|
8041 |
0.16 |
chr1_25311224_25311505 | 1.60 |
RUNX3 |
runt-related transcription factor 3 |
19863 |
0.18 |
chr8_144655209_144655539 | 1.59 |
MROH6 |
maestro heat-like repeat family member 6 |
233 |
0.51 |
chr1_28586799_28587133 | 1.59 |
SESN2 |
sestrin 2 |
928 |
0.45 |
chr21_44835236_44835488 | 1.59 |
SIK1 |
salt-inducible kinase 1 |
11646 |
0.28 |
chr17_37250282_37250699 | 1.59 |
ENSG00000222494 |
. |
13172 |
0.14 |
chr21_46338196_46338426 | 1.59 |
ITGB2 |
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
2459 |
0.16 |
chr3_13057227_13057378 | 1.59 |
IQSEC1 |
IQ motif and Sec7 domain 1 |
28766 |
0.23 |
chr16_88768919_88769359 | 1.59 |
RNF166 |
ring finger protein 166 |
886 |
0.31 |
chr4_2293050_2293361 | 1.59 |
ZFYVE28 |
zinc finger, FYVE domain containing 28 |
3763 |
0.15 |
chr15_78395422_78395756 | 1.58 |
SH2D7 |
SH2 domain containing 7 |
10662 |
0.13 |
chr12_131995509_131995912 | 1.57 |
ENSG00000212154 |
. |
149898 |
0.04 |
chr20_62668233_62668488 | 1.57 |
ZNF512B |
zinc finger protein 512B |
1578 |
0.21 |
chr6_167534419_167534775 | 1.56 |
CCR6 |
chemokine (C-C motif) receptor 6 |
1660 |
0.37 |
chrX_153582032_153582208 | 1.56 |
FLNA |
filamin A, alpha |
583 |
0.57 |
chr2_113937603_113937798 | 1.56 |
AC016683.5 |
|
4763 |
0.16 |
chr19_47290243_47290479 | 1.56 |
SLC1A5 |
solute carrier family 1 (neutral amino acid transporter), member 5 |
238 |
0.89 |
chr17_80187474_80187768 | 1.56 |
SLC16A3 |
solute carrier family 16 (monocarboxylate transporter), member 3 |
652 |
0.55 |
chr11_67046241_67046409 | 1.56 |
ANKRD13D |
ankyrin repeat domain 13 family, member D |
9693 |
0.11 |
chr9_92097148_92097521 | 1.56 |
SEMA4D |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D |
2529 |
0.33 |
chr16_29164996_29165147 | 1.56 |
CTB-134H23.3 |
|
46305 |
0.11 |
chr5_11233980_11234297 | 1.55 |
ENSG00000207312 |
. |
206826 |
0.03 |
chr14_102063212_102063453 | 1.54 |
DIO3 |
deiodinase, iodothyronine, type III |
35644 |
0.15 |
chr8_142414415_142414628 | 1.53 |
CTD-3064M3.4 |
|
11847 |
0.12 |
chr1_1140948_1141273 | 1.53 |
TNFRSF18 |
tumor necrosis factor receptor superfamily, member 18 |
50 |
0.93 |
chr17_80259260_80259561 | 1.53 |
CD7 |
CD7 molecule |
16018 |
0.1 |
chr1_1951537_1951716 | 1.53 |
GABRD |
gamma-aminobutyric acid (GABA) A receptor, delta |
846 |
0.49 |
chr16_88766157_88766414 | 1.53 |
RNF166 |
ring finger protein 166 |
171 |
0.86 |
chr20_31560402_31560699 | 1.52 |
EFCAB8 |
EF-hand calcium binding domain 8 |
12899 |
0.15 |
chr2_101171269_101171480 | 1.52 |
ENSG00000266005 |
. |
1138 |
0.46 |
chr1_9687682_9687977 | 1.51 |
PIK3CD |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta |
23961 |
0.14 |
chr16_30671534_30671721 | 1.51 |
FBRS |
fibrosin |
384 |
0.7 |
chr6_35279762_35280244 | 1.51 |
DEF6 |
differentially expressed in FDCP 6 homolog (mouse) |
2488 |
0.27 |
chr10_134429030_134429352 | 1.50 |
INPP5A |
inositol polyphosphate-5-phosphatase, 40kDa |
7761 |
0.27 |
chr19_6424039_6424190 | 1.50 |
KHSRP |
KH-type splicing regulatory protein |
174 |
0.88 |
chr10_126300000_126300388 | 1.49 |
FAM53B-AS1 |
FAM53B antisense RNA 1 |
92000 |
0.07 |
chr19_10663855_10664009 | 1.49 |
ENSG00000221410 |
. |
1134 |
0.23 |
chr19_14228029_14228210 | 1.49 |
PRKACA |
protein kinase, cAMP-dependent, catalytic, alpha |
425 |
0.67 |
chr9_126138722_126138873 | 1.49 |
CRB2 |
crumbs homolog 2 (Drosophila) |
7629 |
0.23 |
chr17_76121997_76122236 | 1.49 |
TMC6 |
transmembrane channel-like 6 |
985 |
0.4 |
chr9_132630795_132631295 | 1.49 |
USP20 |
ubiquitin specific peptidase 20 |
33288 |
0.12 |
chr9_126102506_126102867 | 1.49 |
CRB2 |
crumbs homolog 2 (Drosophila) |
15763 |
0.22 |
chr7_45016076_45016453 | 1.49 |
MYO1G |
myosin IG |
2433 |
0.2 |
chr17_8844881_8845564 | 1.48 |
PIK3R5 |
phosphoinositide-3-kinase, regulatory subunit 5 |
23802 |
0.21 |
chr11_60849797_60850034 | 1.48 |
CD5 |
CD5 molecule |
19952 |
0.16 |
chr9_140282226_140282466 | 1.47 |
ENSG00000272272 |
. |
33250 |
0.09 |
chr17_72753486_72753694 | 1.47 |
SLC9A3R1 |
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 1 |
4552 |
0.11 |
chr10_133973135_133973286 | 1.47 |
RP11-140A10.3 |
|
25293 |
0.18 |
chr12_7067049_7067256 | 1.47 |
ENSG00000207713 |
. |
5710 |
0.06 |
chr14_102002023_102002232 | 1.47 |
ENSG00000258498 |
. |
24632 |
0.17 |
chr9_134460225_134460628 | 1.46 |
RAPGEF1 |
Rap guanine nucleotide exchange factor (GEF) 1 |
36799 |
0.13 |
chr19_54871568_54871766 | 1.46 |
LAIR1 |
leukocyte-associated immunoglobulin-like receptor 1 |
889 |
0.43 |
chr11_117886387_117886681 | 1.46 |
IL10RA |
interleukin 10 receptor, alpha |
29425 |
0.14 |
chr11_46367187_46367549 | 1.44 |
DGKZ |
diacylglycerol kinase, zeta |
381 |
0.82 |
chr14_105532821_105533069 | 1.44 |
GPR132 |
G protein-coupled receptor 132 |
1163 |
0.49 |
chr19_13993263_13993689 | 1.44 |
NANOS3 |
nanos homolog 3 (Drosophila) |
5413 |
0.09 |
chr11_67177124_67177505 | 1.43 |
TBC1D10C |
TBC1 domain family, member 10C |
5654 |
0.07 |
chr19_14094328_14094893 | 1.43 |
RFX1 |
regulatory factor X, 1 (influences HLA class II expression) |
22464 |
0.09 |
chr11_69456900_69457051 | 1.43 |
CCND1 |
cyclin D1 |
1001 |
0.59 |
chr7_6663355_6663506 | 1.43 |
ZNF853 |
zinc finger protein 853 |
8182 |
0.13 |
chr8_42188476_42188627 | 1.43 |
POLB |
polymerase (DNA directed), beta |
7421 |
0.18 |
chr18_60825707_60826108 | 1.43 |
RP11-299P2.1 |
|
7354 |
0.25 |
chr19_46295408_46295559 | 1.43 |
DMWD |
dystrophia myotonica, WD repeat containing |
212 |
0.85 |
chr11_68038659_68039198 | 1.43 |
C11orf24 |
chromosome 11 open reading frame 24 |
487 |
0.82 |
chr14_93500721_93500992 | 1.43 |
ITPK1 |
inositol-tetrakisphosphate 1-kinase |
31847 |
0.17 |
chr2_16105641_16106067 | 1.42 |
ENSG00000243541 |
. |
14751 |
0.18 |
chr7_156932251_156932402 | 1.42 |
UBE3C |
ubiquitin protein ligase E3C |
437 |
0.86 |
chr1_68298304_68298660 | 1.42 |
GNG12-AS1 |
GNG12 antisense RNA 1 |
490 |
0.57 |
chr16_691369_691551 | 1.42 |
FAM195A |
family with sequence similarity 195, member A |
353 |
0.64 |
chr10_126850115_126850433 | 1.42 |
CTBP2 |
C-terminal binding protein 2 |
644 |
0.82 |
chr11_61100062_61100329 | 1.42 |
DDB1 |
damage-specific DNA binding protein 1, 127kDa |
112 |
0.84 |
chr20_61636476_61636627 | 1.41 |
BHLHE23 |
basic helix-loop-helix family, member e23 |
1836 |
0.33 |
chr11_1568905_1569175 | 1.41 |
DUSP8 |
dual specificity phosphatase 8 |
18126 |
0.12 |
chr3_13388429_13388737 | 1.41 |
NUP210 |
nucleoporin 210kDa |
73226 |
0.11 |
chr12_7067345_7067996 | 1.41 |
ENSG00000207713 |
. |
5192 |
0.06 |
chr16_3057668_3058079 | 1.41 |
LA16c-380H5.2 |
|
2771 |
0.09 |
chr11_2320673_2321045 | 1.41 |
C11orf21 |
chromosome 11 open reading frame 21 |
2284 |
0.19 |
chr2_98334776_98334948 | 1.40 |
ZAP70 |
zeta-chain (TCR) associated protein kinase 70kDa |
4839 |
0.19 |
chr1_43396254_43396405 | 1.40 |
SLC2A1 |
solute carrier family 2 (facilitated glucose transporter), member 1 |
467 |
0.82 |
chr15_31557369_31557520 | 1.40 |
KLF13 |
Kruppel-like factor 13 |
61614 |
0.14 |
chr9_134134182_134134333 | 1.39 |
FAM78A |
family with sequence similarity 78, member A |
11623 |
0.17 |
chr19_45350688_45350898 | 1.39 |
PVRL2 |
poliovirus receptor-related 2 (herpesvirus entry mediator B) |
1010 |
0.39 |
chr19_45668417_45668581 | 1.39 |
NKPD1 |
NTPase, KAP family P-loop domain containing 1 |
5091 |
0.11 |
chr11_1777921_1778072 | 1.39 |
CTSD |
cathepsin D |
1820 |
0.16 |
chr8_38325731_38325987 | 1.39 |
FGFR1 |
fibroblast growth factor receptor 1 |
275 |
0.9 |
chrY_1533200_1533719 | 1.39 |
NA |
NA |
> 106 |
NA |
chr20_17592532_17592683 | 1.38 |
ENSG00000202260 |
. |
35452 |
0.13 |
chr16_88765577_88765835 | 1.38 |
RNF166 |
ring finger protein 166 |
408 |
0.63 |
chr13_114909698_114910252 | 1.38 |
RASA3 |
RAS p21 protein activator 3 |
11889 |
0.21 |
chr9_117132575_117132773 | 1.38 |
AKNA |
AT-hook transcription factor |
6570 |
0.21 |
chr10_3462374_3462591 | 1.38 |
PITRM1 |
pitrilysin metallopeptidase 1 |
247479 |
0.02 |
chr3_13111271_13111777 | 1.38 |
IQSEC1 |
IQ motif and Sec7 domain 1 |
3093 |
0.38 |
chr4_1753783_1753977 | 1.38 |
TACC3 |
transforming, acidic coiled-coil containing protein 3 |
23749 |
0.13 |
chr3_66023505_66023773 | 1.38 |
MAGI1 |
membrane associated guanylate kinase, WW and PDZ domain containing 1 |
344 |
0.9 |
chr1_206734149_206734498 | 1.38 |
RASSF5 |
Ras association (RalGDS/AF-6) domain family member 5 |
3830 |
0.2 |
chr1_27160442_27160760 | 1.38 |
ZDHHC18 |
zinc finger, DHHC-type containing 18 |
2090 |
0.2 |
chr1_182360343_182360566 | 1.38 |
GLUL |
glutamate-ammonia ligase |
85 |
0.97 |
chr9_92153229_92153575 | 1.37 |
SEMA4D |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D |
40357 |
0.16 |
chr10_130856557_130857124 | 1.37 |
MGMT |
O-6-methylguanine-DNA methyltransferase |
408608 |
0.01 |
chr19_55020227_55020521 | 1.37 |
LAIR2 |
leukocyte-associated immunoglobulin-like receptor 2 |
6251 |
0.11 |
chr16_3070538_3070989 | 1.37 |
TNFRSF12A |
tumor necrosis factor receptor superfamily, member 12A |
383 |
0.5 |
chr14_91783405_91783878 | 1.36 |
ENSG00000265856 |
. |
16416 |
0.19 |
chr18_74765879_74766101 | 1.36 |
MBP |
myelin basic protein |
36256 |
0.2 |
chr17_79261558_79261764 | 1.36 |
SLC38A10 |
solute carrier family 38, member 10 |
5597 |
0.14 |
chr17_75842366_75842622 | 1.36 |
FLJ45079 |
|
36165 |
0.19 |
chr14_104858810_104858961 | 1.36 |
ENSG00000222761 |
. |
8500 |
0.27 |
chr6_13428716_13429009 | 1.36 |
GFOD1 |
glucose-fructose oxidoreductase domain containing 1 |
20493 |
0.18 |
chr19_12832299_12832694 | 1.36 |
TNPO2 |
transportin 2 |
33 |
0.93 |
chr17_79318767_79318934 | 1.36 |
TMEM105 |
transmembrane protein 105 |
14376 |
0.13 |
chr14_91842844_91843127 | 1.36 |
CCDC88C |
coiled-coil domain containing 88C |
40705 |
0.15 |
chr14_105543973_105544183 | 1.36 |
GPR132 |
G protein-coupled receptor 132 |
12296 |
0.18 |
chr2_219269324_219269539 | 1.36 |
ENSG00000199121 |
. |
2062 |
0.17 |
chr18_77161709_77162041 | 1.36 |
NFATC1 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 |
1483 |
0.49 |
chr19_47226010_47226260 | 1.35 |
STRN4 |
striatin, calmodulin binding protein 4 |
333 |
0.76 |
chr22_19595594_19595745 | 1.35 |
CLDN5 |
claudin 5 |
80601 |
0.07 |
chr9_134127671_134127998 | 1.35 |
FAM78A |
family with sequence similarity 78, member A |
18046 |
0.15 |
chr7_150706994_150707399 | 1.35 |
NOS3 |
nitric oxide synthase 3 (endothelial cell) |
1171 |
0.31 |
chr8_144452193_144452436 | 1.35 |
RHPN1 |
rhophilin, Rho GTPase binding protein 1 |
1257 |
0.25 |
chr18_43924333_43924921 | 1.35 |
RNF165 |
ring finger protein 165 |
10440 |
0.28 |
chr10_134264591_134264838 | 1.35 |
C10orf91 |
chromosome 10 open reading frame 91 |
6021 |
0.19 |
chr8_67342216_67342464 | 1.35 |
ADHFE1 |
alcohol dehydrogenase, iron containing, 1 |
80 |
0.95 |
chr19_5131953_5132104 | 1.35 |
CTC-482H14.5 |
|
46102 |
0.14 |
chr17_56411702_56411930 | 1.35 |
ENSG00000264399 |
. |
1567 |
0.22 |
chr16_29756155_29756375 | 1.34 |
AC009133.17 |
|
303 |
0.74 |
chr6_35277788_35277984 | 1.34 |
DEF6 |
differentially expressed in FDCP 6 homolog (mouse) |
371 |
0.86 |
chr9_100937607_100937767 | 1.34 |
CORO2A |
coronin, actin binding protein, 2A |
2521 |
0.31 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.4 | 7.2 | GO:0030223 | neutrophil differentiation(GO:0030223) |
1.8 | 5.5 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
1.7 | 5.0 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
1.7 | 5.0 | GO:0018094 | protein polyglycylation(GO:0018094) |
1.5 | 1.5 | GO:0051155 | positive regulation of striated muscle cell differentiation(GO:0051155) |
1.5 | 7.4 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
1.4 | 7.2 | GO:0090205 | positive regulation of cholesterol metabolic process(GO:0090205) |
1.4 | 4.1 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
1.3 | 6.7 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
1.3 | 5.3 | GO:0032661 | interleukin-18 production(GO:0032621) regulation of interleukin-18 production(GO:0032661) |
1.3 | 1.3 | GO:0051928 | positive regulation of calcium ion transport(GO:0051928) |
1.2 | 3.7 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
1.2 | 4.9 | GO:0070141 | response to UV-A(GO:0070141) |
1.2 | 3.7 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
1.2 | 8.2 | GO:0045061 | thymic T cell selection(GO:0045061) |
1.2 | 4.6 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
1.1 | 6.7 | GO:0045588 | gamma-delta T cell differentiation(GO:0042492) regulation of gamma-delta T cell differentiation(GO:0045586) positive regulation of gamma-delta T cell differentiation(GO:0045588) regulation of gamma-delta T cell activation(GO:0046643) positive regulation of gamma-delta T cell activation(GO:0046645) |
1.1 | 3.3 | GO:0097576 | vacuole fusion(GO:0097576) |
1.1 | 3.2 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) glial cell fate specification(GO:0021780) |
1.0 | 2.1 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) |
1.0 | 3.1 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
1.0 | 7.1 | GO:0007172 | signal complex assembly(GO:0007172) |
1.0 | 3.1 | GO:0031558 | obsolete induction of apoptosis in response to chemical stimulus(GO:0031558) |
1.0 | 1.0 | GO:0071503 | response to heparin(GO:0071503) |
1.0 | 3.0 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
1.0 | 4.0 | GO:0000089 | mitotic metaphase(GO:0000089) |
1.0 | 3.0 | GO:0003077 | obsolete negative regulation of diuresis(GO:0003077) |
1.0 | 3.0 | GO:0072162 | mesenchymal cell differentiation involved in kidney development(GO:0072161) metanephric mesenchymal cell differentiation(GO:0072162) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
1.0 | 2.0 | GO:0072224 | metanephric glomerulus development(GO:0072224) metanephric glomerulus vasculature development(GO:0072239) |
1.0 | 3.9 | GO:0014805 | smooth muscle adaptation(GO:0014805) |
1.0 | 2.9 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
1.0 | 1.0 | GO:0035412 | catenin import into nucleus(GO:0035411) regulation of catenin import into nucleus(GO:0035412) |
1.0 | 2.9 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
1.0 | 2.9 | GO:0036037 | CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
1.0 | 1.0 | GO:0008347 | glial cell migration(GO:0008347) |
0.9 | 2.8 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.9 | 4.6 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.9 | 2.7 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.9 | 0.9 | GO:0048145 | regulation of fibroblast proliferation(GO:0048145) |
0.9 | 3.6 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.9 | 2.7 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.9 | 0.9 | GO:0060685 | regulation of prostatic bud formation(GO:0060685) |
0.9 | 1.8 | GO:0061054 | dermatome development(GO:0061054) |
0.9 | 1.7 | GO:0060242 | contact inhibition(GO:0060242) |
0.9 | 13.0 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.9 | 4.3 | GO:0033084 | regulation of immature T cell proliferation in thymus(GO:0033084) |
0.9 | 3.5 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.9 | 0.9 | GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway(GO:0031664) |
0.9 | 0.9 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.8 | 2.5 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.8 | 2.5 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.8 | 0.8 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.8 | 20.1 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.8 | 3.3 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.8 | 3.3 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.8 | 6.5 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.8 | 2.4 | GO:0043320 | natural killer cell activation involved in immune response(GO:0002323) natural killer cell degranulation(GO:0043320) |
0.8 | 8.8 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.8 | 2.4 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.8 | 0.8 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.8 | 2.4 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.8 | 4.8 | GO:0002063 | chondrocyte development(GO:0002063) |
0.8 | 3.9 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.8 | 2.3 | GO:0006154 | adenosine catabolic process(GO:0006154) |
0.8 | 1.6 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
0.8 | 3.1 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.8 | 2.3 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.8 | 2.3 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.8 | 0.8 | GO:0000255 | allantoin metabolic process(GO:0000255) creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
0.8 | 0.8 | GO:0060430 | lung saccule development(GO:0060430) Type II pneumocyte differentiation(GO:0060510) |
0.7 | 1.5 | GO:0002874 | chronic inflammatory response to antigenic stimulus(GO:0002439) regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
0.7 | 1.5 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.7 | 2.2 | GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002923) |
0.7 | 0.7 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.7 | 2.2 | GO:0090322 | regulation of superoxide metabolic process(GO:0090322) |
0.7 | 0.7 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.7 | 0.7 | GO:0006927 | obsolete transformed cell apoptotic process(GO:0006927) |
0.7 | 0.7 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.7 | 2.9 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.7 | 2.1 | GO:0050870 | positive regulation of T cell activation(GO:0050870) positive regulation of leukocyte cell-cell adhesion(GO:1903039) |
0.7 | 3.5 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.7 | 2.8 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.7 | 2.7 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) |
0.7 | 2.1 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.7 | 3.4 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.7 | 2.0 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.7 | 1.3 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.7 | 0.7 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.7 | 0.7 | GO:0046931 | pore complex assembly(GO:0046931) |
0.7 | 2.0 | GO:0045046 | protein import into peroxisome membrane(GO:0045046) |
0.7 | 2.0 | GO:1901534 | positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.7 | 0.7 | GO:0003157 | endocardium development(GO:0003157) endocardium morphogenesis(GO:0003160) |
0.7 | 4.0 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.7 | 1.3 | GO:0006922 | obsolete cleavage of lamin involved in execution phase of apoptosis(GO:0006922) |
0.7 | 1.3 | GO:0003181 | atrioventricular valve development(GO:0003171) atrioventricular valve morphogenesis(GO:0003181) |
0.7 | 0.7 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.7 | 3.3 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.7 | 1.3 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.7 | 3.3 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.6 | 0.6 | GO:0051665 | membrane raft localization(GO:0051665) |
0.6 | 1.3 | GO:0051446 | positive regulation of meiotic nuclear division(GO:0045836) positive regulation of meiotic cell cycle(GO:0051446) |
0.6 | 1.9 | GO:0031100 | organ regeneration(GO:0031100) |
0.6 | 2.5 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
0.6 | 0.6 | GO:0002085 | inhibition of neuroepithelial cell differentiation(GO:0002085) |
0.6 | 3.1 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.6 | 1.2 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.6 | 31.8 | GO:0031295 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.6 | 0.6 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.6 | 0.6 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.6 | 3.0 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.6 | 0.6 | GO:0002507 | tolerance induction(GO:0002507) |
0.6 | 1.8 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.6 | 2.4 | GO:0000154 | rRNA modification(GO:0000154) |
0.6 | 1.8 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.6 | 1.2 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.6 | 1.8 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.6 | 2.4 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.6 | 0.6 | GO:0045909 | positive regulation of vasodilation(GO:0045909) |
0.6 | 1.8 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
0.6 | 1.8 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.6 | 6.4 | GO:0031648 | protein destabilization(GO:0031648) |
0.6 | 1.2 | GO:0033085 | negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
0.6 | 3.5 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.6 | 1.1 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.6 | 1.1 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) mature B cell differentiation(GO:0002335) |
0.6 | 3.4 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.6 | 0.6 | GO:0048664 | neuron fate determination(GO:0048664) |
0.6 | 2.3 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
0.6 | 0.6 | GO:0007144 | female meiosis I(GO:0007144) |
0.6 | 0.6 | GO:0017085 | response to insecticide(GO:0017085) |
0.6 | 1.7 | GO:0003057 | regulation of the force of heart contraction by chemical signal(GO:0003057) |
0.6 | 2.2 | GO:0042441 | eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
0.6 | 2.2 | GO:0060251 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) regulation of glial cell proliferation(GO:0060251) negative regulation of glial cell proliferation(GO:0060253) |
0.6 | 2.8 | GO:0042634 | regulation of hair cycle(GO:0042634) |
0.6 | 0.6 | GO:0034625 | fatty acid elongation, monounsaturated fatty acid(GO:0034625) |
0.6 | 1.7 | GO:0046015 | carbon catabolite regulation of transcription(GO:0045990) regulation of transcription by glucose(GO:0046015) |
0.6 | 2.2 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.5 | 2.2 | GO:0072498 | embryonic skeletal joint morphogenesis(GO:0060272) embryonic skeletal joint development(GO:0072498) |
0.5 | 1.1 | GO:0090382 | phagolysosome assembly(GO:0001845) phagosome maturation(GO:0090382) |
0.5 | 2.2 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.5 | 1.6 | GO:0001961 | positive regulation of cytokine-mediated signaling pathway(GO:0001961) |
0.5 | 3.2 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.5 | 4.9 | GO:0045022 | early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
0.5 | 1.1 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
0.5 | 3.2 | GO:0045885 | obsolete positive regulation of survival gene product expression(GO:0045885) |
0.5 | 1.6 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.5 | 1.6 | GO:0090281 | negative regulation of calcium ion import(GO:0090281) |
0.5 | 1.6 | GO:0002823 | negative regulation of adaptive immune response(GO:0002820) negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains(GO:0002823) |
0.5 | 3.7 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.5 | 1.6 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.5 | 1.1 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.5 | 0.5 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.5 | 0.5 | GO:0002448 | mast cell mediated immunity(GO:0002448) |
0.5 | 1.1 | GO:0060437 | lung growth(GO:0060437) |
0.5 | 2.1 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) |
0.5 | 3.7 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.5 | 0.5 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.5 | 0.5 | GO:0051321 | meiotic cell cycle(GO:0051321) |
0.5 | 1.6 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.5 | 0.5 | GO:0002467 | germinal center formation(GO:0002467) |
0.5 | 2.6 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.5 | 2.1 | GO:0031442 | positive regulation of mRNA 3'-end processing(GO:0031442) positive regulation of mRNA processing(GO:0050685) positive regulation of mRNA metabolic process(GO:1903313) |
0.5 | 1.0 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.5 | 4.1 | GO:0003407 | neural retina development(GO:0003407) |
0.5 | 0.5 | GO:0045625 | regulation of T-helper 1 cell differentiation(GO:0045625) |
0.5 | 1.5 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.5 | 0.5 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.5 | 4.1 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.5 | 14.8 | GO:0050772 | positive regulation of axonogenesis(GO:0050772) |
0.5 | 3.6 | GO:0050957 | equilibrioception(GO:0050957) |
0.5 | 1.0 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.5 | 0.5 | GO:0052251 | induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) |
0.5 | 0.5 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.5 | 2.5 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.5 | 1.0 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.5 | 4.0 | GO:1904031 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.5 | 1.0 | GO:0031057 | negative regulation of histone modification(GO:0031057) |
0.5 | 1.0 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.5 | 1.0 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.5 | 8.4 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
0.5 | 1.5 | GO:0031034 | skeletal muscle myosin thick filament assembly(GO:0030241) myosin filament organization(GO:0031033) myosin filament assembly(GO:0031034) striated muscle myosin thick filament assembly(GO:0071688) |
0.5 | 1.5 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.5 | 2.0 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.5 | 1.0 | GO:0051169 | nuclear transport(GO:0051169) |
0.5 | 4.9 | GO:0000303 | response to superoxide(GO:0000303) |
0.5 | 2.9 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.5 | 0.5 | GO:0048069 | eye pigmentation(GO:0048069) |
0.5 | 0.5 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.5 | 2.4 | GO:0002329 | immature B cell differentiation(GO:0002327) pre-B cell differentiation(GO:0002329) |
0.5 | 1.5 | GO:0051532 | NFAT protein import into nucleus(GO:0051531) regulation of NFAT protein import into nucleus(GO:0051532) |
0.5 | 1.9 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.5 | 1.4 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.5 | 1.0 | GO:0019724 | B cell mediated immunity(GO:0019724) |
0.5 | 0.5 | GO:0034765 | regulation of ion transmembrane transport(GO:0034765) |
0.5 | 4.3 | GO:0042354 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.5 | 2.4 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.5 | 1.4 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.5 | 0.5 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.5 | 0.5 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.5 | 1.9 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.5 | 1.4 | GO:0090201 | negative regulation of mitochondrion organization(GO:0010823) negative regulation of release of cytochrome c from mitochondria(GO:0090201) negative regulation of apoptotic signaling pathway(GO:2001234) |
0.5 | 3.3 | GO:0050856 | regulation of T cell receptor signaling pathway(GO:0050856) |
0.5 | 0.5 | GO:0048634 | regulation of muscle organ development(GO:0048634) |
0.5 | 2.8 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.5 | 8.8 | GO:0045576 | mast cell activation(GO:0045576) |
0.5 | 1.8 | GO:0001553 | luteinization(GO:0001553) |
0.5 | 0.9 | GO:0071674 | regulation of macrophage chemotaxis(GO:0010758) positive regulation of macrophage chemotaxis(GO:0010759) mononuclear cell migration(GO:0071674) regulation of mononuclear cell migration(GO:0071675) |
0.5 | 0.5 | GO:0002634 | regulation of germinal center formation(GO:0002634) |
0.5 | 1.4 | GO:0090399 | replicative senescence(GO:0090399) |
0.5 | 3.6 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.5 | 1.4 | GO:0042345 | regulation of NF-kappaB import into nucleus(GO:0042345) NF-kappaB import into nucleus(GO:0042348) |
0.5 | 0.9 | GO:1901797 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) negative regulation of signal transduction by p53 class mediator(GO:1901797) |
0.5 | 6.8 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.4 | 3.6 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.4 | 0.9 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.4 | 2.7 | GO:0032735 | positive regulation of interleukin-12 production(GO:0032735) |
0.4 | 2.2 | GO:0033261 | obsolete regulation of S phase(GO:0033261) |
0.4 | 1.3 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.4 | 1.3 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.4 | 4.5 | GO:0001706 | endoderm formation(GO:0001706) |
0.4 | 4.0 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.4 | 0.9 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.4 | 1.8 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
0.4 | 0.4 | GO:0019674 | NAD metabolic process(GO:0019674) |
0.4 | 3.1 | GO:0008653 | lipopolysaccharide metabolic process(GO:0008653) |
0.4 | 1.3 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.4 | 1.3 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.4 | 1.8 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.4 | 0.9 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.4 | 0.4 | GO:0090009 | primitive streak formation(GO:0090009) |
0.4 | 0.4 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) DNA replication, removal of RNA primer(GO:0043137) |
0.4 | 0.9 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.4 | 1.3 | GO:0030186 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.4 | 1.7 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.4 | 1.3 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.4 | 2.6 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.4 | 1.7 | GO:0060122 | inner ear receptor stereocilium organization(GO:0060122) |
0.4 | 2.2 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.4 | 0.9 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
0.4 | 0.4 | GO:0043113 | receptor clustering(GO:0043113) |
0.4 | 1.7 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.4 | 0.4 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.4 | 1.3 | GO:1904019 | endothelial cell apoptotic process(GO:0072577) epithelial cell apoptotic process(GO:1904019) regulation of epithelial cell apoptotic process(GO:1904035) regulation of endothelial cell apoptotic process(GO:2000351) |
0.4 | 0.4 | GO:0051877 | pigment granule aggregation in cell center(GO:0051877) |
0.4 | 0.8 | GO:0022605 | oogenesis stage(GO:0022605) |
0.4 | 1.2 | GO:0035268 | protein mannosylation(GO:0035268) protein O-linked mannosylation(GO:0035269) mannosylation(GO:0097502) |
0.4 | 0.4 | GO:0002691 | regulation of cellular extravasation(GO:0002691) |
0.4 | 1.7 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.4 | 1.2 | GO:0072583 | synaptic vesicle recycling(GO:0036465) synaptic vesicle endocytosis(GO:0048488) clathrin-mediated endocytosis(GO:0072583) |
0.4 | 4.1 | GO:0000085 | mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
0.4 | 1.2 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.4 | 0.4 | GO:0010629 | negative regulation of gene expression(GO:0010629) |
0.4 | 2.4 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.4 | 0.4 | GO:0031646 | positive regulation of neurological system process(GO:0031646) positive regulation of transmission of nerve impulse(GO:0051971) |
0.4 | 1.6 | GO:0003351 | epithelial cilium movement(GO:0003351) epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.4 | 0.4 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.4 | 1.2 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.4 | 0.8 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.4 | 0.4 | GO:0032060 | bleb assembly(GO:0032060) |
0.4 | 0.8 | GO:0010586 | miRNA metabolic process(GO:0010586) miRNA catabolic process(GO:0010587) |
0.4 | 0.8 | GO:0021801 | cerebral cortex radial glia guided migration(GO:0021801) telencephalon glial cell migration(GO:0022030) |
0.4 | 2.4 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.4 | 1.2 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.4 | 2.0 | GO:0060023 | soft palate development(GO:0060023) |
0.4 | 3.5 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.4 | 0.8 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.4 | 1.2 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.4 | 1.9 | GO:0009713 | catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
0.4 | 1.6 | GO:0000101 | sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
0.4 | 0.4 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.4 | 0.8 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.4 | 3.1 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.4 | 0.4 | GO:0021831 | embryonic olfactory bulb interneuron precursor migration(GO:0021831) |
0.4 | 0.4 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.4 | 1.1 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.4 | 0.8 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.4 | 0.4 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.4 | 1.9 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.4 | 0.4 | GO:0070266 | necroptotic process(GO:0070266) programmed necrotic cell death(GO:0097300) |
0.4 | 4.9 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.4 | 2.3 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.4 | 0.4 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
0.4 | 7.1 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.4 | 0.7 | GO:0090047 | obsolete positive regulation of transcription regulator activity(GO:0090047) |
0.4 | 2.2 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.4 | 0.7 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.4 | 0.4 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
0.4 | 4.5 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
0.4 | 1.5 | GO:0097094 | cranial suture morphogenesis(GO:0060363) craniofacial suture morphogenesis(GO:0097094) |
0.4 | 0.4 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.4 | 0.7 | GO:0060596 | mammary placode formation(GO:0060596) |
0.4 | 1.5 | GO:0042308 | negative regulation of protein import into nucleus(GO:0042308) negative regulation of nucleocytoplasmic transport(GO:0046823) negative regulation of protein localization to nucleus(GO:1900181) negative regulation of protein import(GO:1904590) |
0.4 | 0.4 | GO:0045767 | obsolete regulation of anti-apoptosis(GO:0045767) |
0.4 | 18.0 | GO:0006968 | cellular defense response(GO:0006968) |
0.4 | 1.1 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.4 | 0.4 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.4 | 1.1 | GO:0032232 | negative regulation of actin filament bundle assembly(GO:0032232) negative regulation of stress fiber assembly(GO:0051497) |
0.4 | 0.7 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
0.4 | 1.1 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.4 | 0.7 | GO:0045683 | negative regulation of epidermal cell differentiation(GO:0045605) negative regulation of keratinocyte differentiation(GO:0045617) negative regulation of epidermis development(GO:0045683) |
0.4 | 1.1 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.4 | 1.5 | GO:0019441 | tryptophan catabolic process to kynurenine(GO:0019441) |
0.4 | 1.1 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.4 | 1.5 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.4 | 0.4 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.4 | 1.1 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.4 | 1.1 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.4 | 2.2 | GO:0006546 | glycine catabolic process(GO:0006546) |
0.4 | 1.1 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
0.4 | 0.7 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.4 | 0.4 | GO:0032647 | interferon-alpha production(GO:0032607) regulation of interferon-alpha production(GO:0032647) |
0.4 | 2.5 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.4 | 5.0 | GO:0030593 | neutrophil chemotaxis(GO:0030593) neutrophil migration(GO:1990266) |
0.4 | 1.1 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.4 | 1.4 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.4 | 1.1 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.4 | 1.4 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.4 | 2.5 | GO:0006839 | mitochondrial transport(GO:0006839) |
0.4 | 5.0 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.4 | 1.4 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.4 | 0.4 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.4 | 7.5 | GO:0046847 | filopodium assembly(GO:0046847) |
0.4 | 1.4 | GO:0051788 | response to misfolded protein(GO:0051788) |
0.4 | 2.1 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.4 | 1.1 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.4 | 1.8 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.4 | 1.1 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.4 | 0.7 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.4 | 0.7 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
0.4 | 1.1 | GO:0033145 | positive regulation of intracellular steroid hormone receptor signaling pathway(GO:0033145) |
0.4 | 0.7 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.4 | 0.4 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
0.4 | 0.7 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.4 | 2.1 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.4 | 0.4 | GO:0032729 | positive regulation of interferon-gamma production(GO:0032729) |
0.4 | 2.1 | GO:0006491 | N-glycan processing(GO:0006491) |
0.4 | 2.1 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.4 | 0.4 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.4 | 1.4 | GO:0031498 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.4 | 1.1 | GO:0070295 | renal water absorption(GO:0070295) |
0.4 | 3.5 | GO:0050868 | negative regulation of T cell activation(GO:0050868) negative regulation of leukocyte cell-cell adhesion(GO:1903038) |
0.3 | 0.7 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.3 | 0.7 | GO:0006007 | glucose catabolic process(GO:0006007) |
0.3 | 3.1 | GO:0001662 | behavioral fear response(GO:0001662) |
0.3 | 1.0 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.3 | 2.4 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.3 | 3.5 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.3 | 0.7 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.3 | 1.0 | GO:0045056 | transcytosis(GO:0045056) |
0.3 | 1.7 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.3 | 3.8 | GO:0050850 | positive regulation of calcium-mediated signaling(GO:0050850) |
0.3 | 0.3 | GO:0001705 | ectoderm formation(GO:0001705) |
0.3 | 1.4 | GO:0002097 | tRNA wobble base modification(GO:0002097) tRNA wobble uridine modification(GO:0002098) tRNA thio-modification(GO:0034227) |
0.3 | 0.3 | GO:1901863 | positive regulation of striated muscle tissue development(GO:0045844) positive regulation of muscle organ development(GO:0048636) positive regulation of muscle tissue development(GO:1901863) |
0.3 | 0.7 | GO:0046323 | glucose import(GO:0046323) |
0.3 | 0.7 | GO:0034969 | histone arginine methylation(GO:0034969) |
0.3 | 1.4 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.3 | 0.3 | GO:0043931 | ossification involved in bone maturation(GO:0043931) |
0.3 | 1.4 | GO:0009109 | coenzyme catabolic process(GO:0009109) |
0.3 | 1.0 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.3 | 0.7 | GO:0060049 | regulation of protein glycosylation(GO:0060049) |
0.3 | 1.7 | GO:0006929 | substrate-dependent cell migration(GO:0006929) |
0.3 | 1.7 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.3 | 0.3 | GO:0050672 | negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) |
0.3 | 1.0 | GO:0046398 | UDP-glucuronate metabolic process(GO:0046398) |
0.3 | 0.7 | GO:0071501 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.3 | 1.7 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.3 | 0.3 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.3 | 0.3 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.3 | 1.0 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.3 | 0.7 | GO:0051451 | myoblast migration(GO:0051451) |
0.3 | 0.3 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
0.3 | 4.6 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.3 | 1.3 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.3 | 0.3 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.3 | 3.0 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.3 | 3.0 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
0.3 | 0.7 | GO:0070857 | regulation of bile acid biosynthetic process(GO:0070857) regulation of bile acid metabolic process(GO:1904251) |
0.3 | 1.6 | GO:0009304 | tRNA transcription(GO:0009304) |
0.3 | 2.0 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.3 | 2.6 | GO:1903322 | positive regulation of protein modification by small protein conjugation or removal(GO:1903322) |
0.3 | 1.0 | GO:0009215 | purine deoxyribonucleoside triphosphate metabolic process(GO:0009215) |
0.3 | 0.6 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.3 | 0.6 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.3 | 1.9 | GO:0045730 | respiratory burst(GO:0045730) |
0.3 | 0.6 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.3 | 1.0 | GO:0050665 | hydrogen peroxide biosynthetic process(GO:0050665) |
0.3 | 1.0 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
0.3 | 1.6 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.3 | 1.3 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.3 | 1.0 | GO:0043276 | anoikis(GO:0043276) |
0.3 | 2.5 | GO:0015884 | folic acid transport(GO:0015884) |
0.3 | 0.6 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.3 | 1.9 | GO:0051322 | anaphase(GO:0051322) |
0.3 | 0.9 | GO:0007207 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.3 | 0.9 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.3 | 0.9 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.3 | 0.3 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.3 | 1.6 | GO:0030163 | protein catabolic process(GO:0030163) |
0.3 | 0.6 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.3 | 0.3 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.3 | 0.9 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.3 | 0.6 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.3 | 0.3 | GO:0010517 | regulation of phospholipase activity(GO:0010517) |
0.3 | 0.6 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.3 | 1.9 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.3 | 1.9 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.3 | 0.3 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.3 | 0.3 | GO:0001302 | replicative cell aging(GO:0001302) |
0.3 | 0.3 | GO:0045165 | cell fate commitment(GO:0045165) |
0.3 | 1.8 | GO:0045749 | obsolete negative regulation of S phase of mitotic cell cycle(GO:0045749) |
0.3 | 0.9 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) positive regulation of cell cycle checkpoint(GO:1901978) regulation of mitotic spindle checkpoint(GO:1903504) |
0.3 | 1.5 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.3 | 1.2 | GO:0046606 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.3 | 0.3 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.3 | 1.2 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.3 | 1.5 | GO:0001570 | vasculogenesis(GO:0001570) |
0.3 | 12.4 | GO:0034138 | toll-like receptor 3 signaling pathway(GO:0034138) |
0.3 | 0.6 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.3 | 0.6 | GO:0030330 | DNA damage response, signal transduction by p53 class mediator(GO:0030330) |
0.3 | 1.5 | GO:0006983 | ER overload response(GO:0006983) |
0.3 | 5.4 | GO:0000080 | mitotic G1 phase(GO:0000080) |
0.3 | 0.6 | GO:0071436 | sodium ion export(GO:0071436) |
0.3 | 0.6 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) negative regulation of anion transmembrane transport(GO:1903960) negative regulation of fatty acid transport(GO:2000192) |
0.3 | 1.5 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.3 | 0.3 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.3 | 7.1 | GO:0050680 | negative regulation of epithelial cell proliferation(GO:0050680) |
0.3 | 3.3 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.3 | 1.2 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.3 | 1.2 | GO:0045916 | negative regulation of humoral immune response(GO:0002921) negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.3 | 0.9 | GO:0071428 | rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
0.3 | 8.8 | GO:0010977 | negative regulation of neuron projection development(GO:0010977) |
0.3 | 2.1 | GO:0072506 | phosphate ion homeostasis(GO:0055062) divalent inorganic anion homeostasis(GO:0072505) trivalent inorganic anion homeostasis(GO:0072506) |
0.3 | 0.9 | GO:0007140 | male meiosis(GO:0007140) |
0.3 | 1.5 | GO:0015780 | nucleotide-sugar transport(GO:0015780) |
0.3 | 0.9 | GO:0030516 | regulation of axon extension(GO:0030516) |
0.3 | 0.3 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.3 | 0.9 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.3 | 1.4 | GO:0036230 | granulocyte activation(GO:0036230) |
0.3 | 0.6 | GO:0039656 | modulation by virus of host gene expression(GO:0039656) |
0.3 | 4.0 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.3 | 0.3 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.3 | 0.3 | GO:0002724 | regulation of T cell cytokine production(GO:0002724) |
0.3 | 0.9 | GO:0044091 | membrane biogenesis(GO:0044091) |
0.3 | 2.3 | GO:1903846 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.3 | 0.3 | GO:0001821 | histamine secretion(GO:0001821) |
0.3 | 0.6 | GO:0021681 | cerebellar granular layer development(GO:0021681) cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.3 | 2.8 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.3 | 0.9 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.3 | 0.6 | GO:0019042 | viral latency(GO:0019042) |
0.3 | 0.9 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.3 | 11.9 | GO:0007498 | mesoderm development(GO:0007498) |
0.3 | 0.3 | GO:0050879 | multicellular organismal movement(GO:0050879) musculoskeletal movement(GO:0050881) |
0.3 | 2.8 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.3 | 2.3 | GO:0007007 | inner mitochondrial membrane organization(GO:0007007) |
0.3 | 2.3 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
0.3 | 0.6 | GO:0022602 | ovulation cycle process(GO:0022602) |
0.3 | 0.6 | GO:0007143 | female meiotic division(GO:0007143) |
0.3 | 0.3 | GO:0010389 | regulation of G2/M transition of mitotic cell cycle(GO:0010389) regulation of cell cycle G2/M phase transition(GO:1902749) |
0.3 | 0.8 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.3 | 1.1 | GO:0042506 | tyrosine phosphorylation of Stat5 protein(GO:0042506) |
0.3 | 1.4 | GO:0071445 | obsolete cellular response to protein stimulus(GO:0071445) |
0.3 | 0.6 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.3 | 1.1 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.3 | 0.3 | GO:0001556 | oocyte maturation(GO:0001556) |
0.3 | 0.3 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.3 | 0.3 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
0.3 | 0.8 | GO:0034311 | sphingosine metabolic process(GO:0006670) diol metabolic process(GO:0034311) |
0.3 | 0.5 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.3 | 1.9 | GO:0009650 | UV protection(GO:0009650) |
0.3 | 0.3 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.3 | 0.5 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.3 | 0.5 | GO:0003211 | cardiac chamber formation(GO:0003207) cardiac ventricle formation(GO:0003211) |
0.3 | 1.4 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.3 | 5.5 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.3 | 0.5 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.3 | 0.5 | GO:0030240 | skeletal myofibril assembly(GO:0014866) skeletal muscle thin filament assembly(GO:0030240) |
0.3 | 2.2 | GO:0032456 | endocytic recycling(GO:0032456) |
0.3 | 6.2 | GO:1901799 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) negative regulation of proteasomal protein catabolic process(GO:1901799) |
0.3 | 3.0 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.3 | 2.7 | GO:0010039 | response to iron ion(GO:0010039) |
0.3 | 1.9 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.3 | 0.5 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.3 | 1.1 | GO:0002920 | regulation of humoral immune response(GO:0002920) |
0.3 | 2.1 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.3 | 0.3 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.3 | 0.3 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.3 | 4.5 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.3 | 0.5 | GO:0045684 | positive regulation of epidermis development(GO:0045684) |
0.3 | 0.3 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.3 | 0.3 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.3 | 1.3 | GO:0006906 | vesicle fusion(GO:0006906) |
0.3 | 2.9 | GO:0008380 | RNA splicing(GO:0008380) |
0.3 | 1.3 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.3 | 1.8 | GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) extrinsic apoptotic signaling pathway(GO:0097191) |
0.3 | 2.4 | GO:0006069 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.3 | 0.3 | GO:0051882 | mitochondrial depolarization(GO:0051882) |
0.3 | 0.5 | GO:0032715 | negative regulation of interleukin-6 production(GO:0032715) |
0.3 | 0.3 | GO:0035821 | modification of morphology or physiology of other organism(GO:0035821) |
0.3 | 0.3 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.3 | 1.8 | GO:0006465 | signal peptide processing(GO:0006465) |
0.3 | 0.5 | GO:0018119 | protein nitrosylation(GO:0017014) peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.3 | 1.6 | GO:0030238 | male sex determination(GO:0030238) |
0.3 | 1.6 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.3 | 3.1 | GO:0007032 | endosome organization(GO:0007032) |
0.3 | 1.0 | GO:0000012 | single strand break repair(GO:0000012) |
0.3 | 0.5 | GO:0001881 | receptor recycling(GO:0001881) |
0.3 | 4.1 | GO:0006305 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
0.3 | 8.7 | GO:0030816 | positive regulation of cAMP metabolic process(GO:0030816) positive regulation of cAMP biosynthetic process(GO:0030819) |
0.3 | 0.8 | GO:0001945 | lymph vessel development(GO:0001945) |
0.3 | 0.8 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.3 | 2.5 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.3 | 0.3 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.3 | 0.3 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.3 | 0.8 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.3 | 0.5 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.3 | 2.8 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.3 | 0.3 | GO:0016577 | histone demethylation(GO:0016577) |
0.3 | 0.5 | GO:0072047 | proximal/distal pattern formation involved in nephron development(GO:0072047) specification of nephron tubule identity(GO:0072081) |
0.3 | 0.3 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.3 | 0.3 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.3 | 1.0 | GO:0008218 | bioluminescence(GO:0008218) |
0.3 | 0.5 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.2 | 1.2 | GO:0060761 | negative regulation of response to cytokine stimulus(GO:0060761) |
0.2 | 1.0 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.2 | 1.0 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.2 | 0.7 | GO:0050798 | activated T cell proliferation(GO:0050798) |
0.2 | 0.5 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.2 | 4.4 | GO:0043487 | regulation of RNA stability(GO:0043487) |
0.2 | 0.2 | GO:0033151 | V(D)J recombination(GO:0033151) |
0.2 | 0.2 | GO:0072194 | kidney smooth muscle tissue development(GO:0072194) |
0.2 | 0.7 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.2 | 0.5 | GO:0043949 | regulation of cAMP-mediated signaling(GO:0043949) |
0.2 | 5.6 | GO:1901185 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
0.2 | 0.2 | GO:0006534 | cysteine metabolic process(GO:0006534) |
0.2 | 0.5 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.2 | 1.0 | GO:0019915 | lipid storage(GO:0019915) |
0.2 | 1.2 | GO:0045116 | protein neddylation(GO:0045116) |
0.2 | 2.6 | GO:1905037 | autophagosome assembly(GO:0000045) autophagosome organization(GO:1905037) |
0.2 | 0.2 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.2 | 0.7 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.2 | 1.0 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.2 | 1.0 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.2 | 1.4 | GO:0097384 | cellular lipid biosynthetic process(GO:0097384) |
0.2 | 5.7 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.2 | 0.2 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.2 | 2.6 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.2 | 0.7 | GO:0031507 | heterochromatin assembly(GO:0031507) heterochromatin organization(GO:0070828) |
0.2 | 0.2 | GO:0048675 | axon extension(GO:0048675) neuron projection extension(GO:1990138) |
0.2 | 0.9 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.2 | 0.5 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.2 | 2.8 | GO:0016925 | protein sumoylation(GO:0016925) |
0.2 | 0.2 | GO:0051101 | regulation of DNA binding(GO:0051101) |
0.2 | 2.1 | GO:0019059 | obsolete initiation of viral infection(GO:0019059) |
0.2 | 0.7 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.2 | 0.2 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.2 | 1.2 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.2 | 0.5 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.2 | 0.2 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.2 | 0.9 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.2 | 0.2 | GO:0002532 | production of molecular mediator involved in inflammatory response(GO:0002532) |
0.2 | 0.2 | GO:0000216 | obsolete M/G1 transition of mitotic cell cycle(GO:0000216) |
0.2 | 0.9 | GO:0008584 | male gonad development(GO:0008584) development of primary male sexual characteristics(GO:0046546) |
0.2 | 0.2 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.2 | 0.7 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.2 | 0.7 | GO:0045005 | DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
0.2 | 0.5 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.2 | 0.5 | GO:0006595 | polyamine metabolic process(GO:0006595) |
0.2 | 2.7 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.2 | 1.6 | GO:0007416 | synapse assembly(GO:0007416) |
0.2 | 1.3 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.2 | 0.9 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
0.2 | 0.9 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.2 | 0.2 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.2 | 0.2 | GO:0006273 | lagging strand elongation(GO:0006273) |
0.2 | 0.4 | GO:0010561 | negative regulation of glycoprotein biosynthetic process(GO:0010561) |
0.2 | 0.2 | GO:0046660 | female sex differentiation(GO:0046660) |
0.2 | 0.2 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.2 | 0.4 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.2 | 0.2 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
0.2 | 1.5 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.2 | 1.5 | GO:0007141 | male meiosis I(GO:0007141) |
0.2 | 0.4 | GO:1902117 | positive regulation of organelle assembly(GO:1902117) |
0.2 | 0.4 | GO:0045410 | response to bacterial lipoprotein(GO:0032493) detection of bacterial lipoprotein(GO:0042494) positive regulation of interleukin-6 biosynthetic process(GO:0045410) response to bacterial lipopeptide(GO:0070339) detection of bacterial lipopeptide(GO:0070340) cellular response to bacterial lipoprotein(GO:0071220) cellular response to bacterial lipopeptide(GO:0071221) |
0.2 | 0.2 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.2 | 0.9 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.2 | 0.2 | GO:0043368 | positive T cell selection(GO:0043368) |
0.2 | 0.9 | GO:0019062 | virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) |
0.2 | 1.7 | GO:0006621 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.2 | 0.4 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.2 | 0.4 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.2 | 1.1 | GO:0033692 | cellular polysaccharide biosynthetic process(GO:0033692) |
0.2 | 0.4 | GO:0072600 | protein targeting to Golgi(GO:0000042) establishment of protein localization to Golgi(GO:0072600) |
0.2 | 1.1 | GO:0098534 | centriole replication(GO:0007099) centriole assembly(GO:0098534) |
0.2 | 0.6 | GO:0006565 | L-serine catabolic process(GO:0006565) |
0.2 | 0.4 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.2 | 1.3 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.2 | 2.1 | GO:1901661 | quinone metabolic process(GO:1901661) |
0.2 | 0.8 | GO:0007091 | metaphase/anaphase transition of mitotic cell cycle(GO:0007091) regulation of mitotic sister chromatid separation(GO:0010965) regulation of mitotic sister chromatid segregation(GO:0033047) metaphase/anaphase transition of cell cycle(GO:0044784) mitotic sister chromatid separation(GO:0051306) |
0.2 | 12.3 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
0.2 | 0.2 | GO:0070265 | necrotic cell death(GO:0070265) |
0.2 | 0.4 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.2 | 0.6 | GO:0006477 | protein sulfation(GO:0006477) |
0.2 | 3.1 | GO:0071554 | cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.2 | 0.8 | GO:0072666 | protein targeting to lysosome(GO:0006622) protein targeting to vacuole(GO:0006623) protein localization to lysosome(GO:0061462) protein localization to vacuole(GO:0072665) establishment of protein localization to vacuole(GO:0072666) |
0.2 | 0.6 | GO:0051567 | histone H3-K9 methylation(GO:0051567) histone H3-K9 modification(GO:0061647) |
0.2 | 1.2 | GO:0010259 | multicellular organism aging(GO:0010259) |
0.2 | 0.4 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.2 | 6.6 | GO:0005977 | glycogen metabolic process(GO:0005977) |
0.2 | 0.8 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.2 | 0.6 | GO:0051294 | establishment of mitotic spindle orientation(GO:0000132) establishment of spindle orientation(GO:0051294) |
0.2 | 5.9 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.2 | 1.0 | GO:0030500 | regulation of bone mineralization(GO:0030500) |
0.2 | 1.0 | GO:0042246 | tissue regeneration(GO:0042246) |
0.2 | 0.6 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.2 | 0.8 | GO:0031272 | pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
0.2 | 0.6 | GO:0014904 | myotube cell development(GO:0014904) skeletal muscle fiber development(GO:0048741) |
0.2 | 0.6 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.2 | 1.4 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.2 | 2.0 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.2 | 0.4 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.2 | 1.0 | GO:0002483 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.2 | 1.0 | GO:0070193 | synaptonemal complex organization(GO:0070193) |
0.2 | 0.8 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.2 | 0.4 | GO:0060192 | negative regulation of lipoprotein lipase activity(GO:0051005) negative regulation of lipase activity(GO:0060192) |
0.2 | 0.6 | GO:0006573 | valine metabolic process(GO:0006573) |
0.2 | 0.6 | GO:0046618 | drug export(GO:0046618) |
0.2 | 0.4 | GO:0032106 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) |
0.2 | 7.0 | GO:0010827 | regulation of glucose transport(GO:0010827) |
0.2 | 0.6 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.2 | 0.2 | GO:0010771 | negative regulation of cell morphogenesis involved in differentiation(GO:0010771) |
0.2 | 1.8 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.2 | 0.4 | GO:0034367 | macromolecular complex remodeling(GO:0034367) protein-lipid complex remodeling(GO:0034368) plasma lipoprotein particle remodeling(GO:0034369) |
0.2 | 2.5 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.2 | 1.0 | GO:0016556 | mRNA modification(GO:0016556) |
0.2 | 0.2 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.2 | 0.4 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.2 | 1.2 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.2 | 2.3 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.2 | 3.8 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.2 | 0.2 | GO:0008634 | obsolete negative regulation of survival gene product expression(GO:0008634) |
0.2 | 0.4 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.2 | 0.4 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.2 | 0.4 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.2 | 1.1 | GO:0031647 | regulation of protein stability(GO:0031647) |
0.2 | 0.4 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.2 | 1.0 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.2 | 1.0 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.2 | 0.6 | GO:0034339 | obsolete regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor(GO:0034339) |
0.2 | 0.6 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.2 | 0.7 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.2 | 0.2 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.2 | 0.9 | GO:1903321 | negative regulation of protein modification by small protein conjugation or removal(GO:1903321) |
0.2 | 0.2 | GO:0061339 | establishment of apical/basal cell polarity(GO:0035089) establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
0.2 | 0.6 | GO:0009414 | response to water deprivation(GO:0009414) response to water(GO:0009415) |
0.2 | 0.6 | GO:0034394 | protein localization to cell surface(GO:0034394) |
0.2 | 1.5 | GO:0006401 | RNA catabolic process(GO:0006401) |
0.2 | 1.5 | GO:0001947 | heart looping(GO:0001947) embryonic heart tube morphogenesis(GO:0003143) determination of heart left/right asymmetry(GO:0061371) |
0.2 | 6.3 | GO:0051084 | 'de novo' posttranslational protein folding(GO:0051084) |
0.2 | 0.9 | GO:0019221 | cytokine-mediated signaling pathway(GO:0019221) |
0.2 | 0.4 | GO:0060323 | head morphogenesis(GO:0060323) |
0.2 | 1.3 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.2 | 0.2 | GO:0031223 | auditory behavior(GO:0031223) |
0.2 | 0.2 | GO:0061037 | negative regulation of chondrocyte differentiation(GO:0032331) negative regulation of cartilage development(GO:0061037) |
0.2 | 0.2 | GO:0006111 | regulation of gluconeogenesis(GO:0006111) |
0.2 | 0.2 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.2 | 1.3 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.2 | 0.5 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.2 | 0.5 | GO:0021799 | cerebral cortex radially oriented cell migration(GO:0021799) |
0.2 | 0.2 | GO:0021898 | cerebral cortex GABAergic interneuron differentiation(GO:0021892) commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.2 | 4.3 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.2 | 0.2 | GO:0008593 | regulation of Notch signaling pathway(GO:0008593) |
0.2 | 4.0 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.2 | 0.9 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.2 | 0.4 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
0.2 | 1.6 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) COPII-coated vesicle budding(GO:0090114) |
0.2 | 0.5 | GO:0051926 | negative regulation of calcium ion transport(GO:0051926) |
0.2 | 0.2 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.2 | 0.2 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.2 | 0.2 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.2 | 1.8 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.2 | 0.7 | GO:0018200 | peptidyl-glutamic acid modification(GO:0018200) |
0.2 | 0.4 | GO:0031668 | cellular response to extracellular stimulus(GO:0031668) |
0.2 | 0.4 | GO:0021794 | thalamus development(GO:0021794) |
0.2 | 0.5 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.2 | 0.3 | GO:0050818 | regulation of coagulation(GO:0050818) |
0.2 | 0.5 | GO:0071569 | protein ufmylation(GO:0071569) |
0.2 | 0.2 | GO:1902115 | regulation of organelle assembly(GO:1902115) |
0.2 | 0.7 | GO:0006378 | mRNA polyadenylation(GO:0006378) |
0.2 | 1.7 | GO:0042551 | neuron maturation(GO:0042551) |
0.2 | 0.9 | GO:0010165 | response to X-ray(GO:0010165) |
0.2 | 0.2 | GO:0072148 | epithelial cell fate commitment(GO:0072148) |
0.2 | 1.0 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
0.2 | 0.3 | GO:0031958 | corticosteroid receptor signaling pathway(GO:0031958) glucocorticoid receptor signaling pathway(GO:0042921) |
0.2 | 1.4 | GO:0048536 | spleen development(GO:0048536) |
0.2 | 0.2 | GO:2000758 | positive regulation of histone acetylation(GO:0035066) positive regulation of protein acetylation(GO:1901985) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.2 | 1.9 | GO:0009988 | cell-cell recognition(GO:0009988) |
0.2 | 9.1 | GO:0018279 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.2 | 0.2 | GO:0060456 | regulation of saliva secretion(GO:0046877) positive regulation of digestive system process(GO:0060456) |
0.2 | 0.2 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.2 | 0.2 | GO:0006984 | ER-nucleus signaling pathway(GO:0006984) |
0.2 | 2.9 | GO:0048017 | phosphatidylinositol-mediated signaling(GO:0048015) inositol lipid-mediated signaling(GO:0048017) |
0.2 | 0.8 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.2 | 2.2 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.2 | 0.3 | GO:0008049 | male courtship behavior(GO:0008049) |
0.2 | 0.5 | GO:0001508 | action potential(GO:0001508) |
0.2 | 1.2 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.2 | 2.8 | GO:0019079 | viral genome replication(GO:0019079) |
0.2 | 0.3 | GO:0006298 | mismatch repair(GO:0006298) |
0.2 | 0.5 | GO:0050773 | regulation of dendrite development(GO:0050773) |
0.2 | 0.5 | GO:0043631 | RNA polyadenylation(GO:0043631) |
0.2 | 2.6 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.2 | 0.3 | GO:0048535 | lymph node development(GO:0048535) |
0.2 | 0.2 | GO:0060914 | heart formation(GO:0060914) |
0.2 | 0.6 | GO:0071265 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.2 | 0.3 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.2 | 1.1 | GO:0051789 | obsolete response to protein(GO:0051789) |
0.2 | 2.1 | GO:0042384 | cilium assembly(GO:0042384) |
0.2 | 0.3 | GO:0032418 | lysosome localization(GO:0032418) |
0.2 | 7.3 | GO:0071357 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
0.2 | 3.3 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.2 | 1.6 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.2 | 5.9 | GO:0006898 | receptor-mediated endocytosis(GO:0006898) |
0.2 | 0.3 | GO:0016199 | axon choice point recognition(GO:0016198) axon midline choice point recognition(GO:0016199) |
0.2 | 0.8 | GO:0051452 | intracellular pH reduction(GO:0051452) |
0.2 | 0.5 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.2 | 0.3 | GO:0010821 | regulation of mitochondrion organization(GO:0010821) |
0.2 | 0.5 | GO:0034370 | triglyceride-rich lipoprotein particle remodeling(GO:0034370) very-low-density lipoprotein particle remodeling(GO:0034372) |
0.2 | 5.5 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.2 | 2.2 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.2 | 0.3 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
0.2 | 0.2 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.2 | 1.1 | GO:0051324 | prophase(GO:0051324) |
0.2 | 0.2 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.2 | 0.2 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.2 | 0.3 | GO:0060317 | cardiac epithelial to mesenchymal transition(GO:0060317) |
0.2 | 1.7 | GO:0034612 | response to tumor necrosis factor(GO:0034612) |
0.2 | 0.8 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.2 | 0.3 | GO:0035094 | response to nicotine(GO:0035094) |
0.2 | 0.3 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.2 | 1.4 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.2 | 4.2 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.2 | 1.5 | GO:0051607 | defense response to virus(GO:0051607) |
0.1 | 0.4 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.1 | 0.3 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
0.1 | 0.4 | GO:0042756 | drinking behavior(GO:0042756) |
0.1 | 0.3 | GO:0036473 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) cell death in response to oxidative stress(GO:0036473) |
0.1 | 0.4 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.1 | 0.3 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.1 | 2.1 | GO:0006400 | tRNA modification(GO:0006400) |
0.1 | 0.3 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
0.1 | 0.7 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.1 | 0.3 | GO:0032366 | intracellular sterol transport(GO:0032366) intracellular cholesterol transport(GO:0032367) |
0.1 | 1.0 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.1 | 0.4 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.1 | 0.1 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.1 | 0.1 | GO:0031123 | RNA 3'-end processing(GO:0031123) |
0.1 | 0.3 | GO:1903301 | regulation of glucokinase activity(GO:0033131) positive regulation of glucokinase activity(GO:0033133) regulation of hexokinase activity(GO:1903299) positive regulation of hexokinase activity(GO:1903301) |
0.1 | 2.0 | GO:0051329 | mitotic interphase(GO:0051329) |
0.1 | 0.6 | GO:0006264 | mitochondrial DNA replication(GO:0006264) mitochondrial DNA metabolic process(GO:0032042) |
0.1 | 0.7 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.1 | 0.6 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.1 | 1.4 | GO:0001709 | cell fate determination(GO:0001709) |
0.1 | 0.4 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.1 | 0.7 | GO:0016446 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.1 | 0.3 | GO:0002544 | chronic inflammatory response(GO:0002544) |
0.1 | 0.3 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.1 | 3.7 | GO:0007286 | spermatid development(GO:0007286) |
0.1 | 0.6 | GO:0032411 | positive regulation of transporter activity(GO:0032411) |
0.1 | 0.6 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.1 | 0.4 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.1 | 1.6 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.1 | 1.1 | GO:0050832 | defense response to fungus(GO:0050832) |
0.1 | 0.6 | GO:0007549 | dosage compensation(GO:0007549) |
0.1 | 1.4 | GO:0035601 | protein deacylation(GO:0035601) macromolecule deacylation(GO:0098732) |
0.1 | 0.4 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.1 | 0.1 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.1 | 0.4 | GO:0032202 | telomere assembly(GO:0032202) |
0.1 | 0.7 | GO:0046036 | GTP biosynthetic process(GO:0006183) UTP biosynthetic process(GO:0006228) CTP biosynthetic process(GO:0006241) pyrimidine nucleoside triphosphate biosynthetic process(GO:0009148) pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) CTP metabolic process(GO:0046036) UTP metabolic process(GO:0046051) |
0.1 | 2.1 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.1 | 1.5 | GO:0034968 | histone lysine methylation(GO:0034968) |
0.1 | 28.6 | GO:0006397 | mRNA processing(GO:0006397) |
0.1 | 0.1 | GO:0002366 | cell activation involved in immune response(GO:0002263) leukocyte activation involved in immune response(GO:0002366) |
0.1 | 2.7 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.1 | 0.1 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.1 | 13.9 | GO:0006470 | protein dephosphorylation(GO:0006470) |
0.1 | 1.9 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.1 | 0.1 | GO:0071636 | transforming growth factor beta1 production(GO:0032905) regulation of transforming growth factor beta1 production(GO:0032908) positive regulation of transforming growth factor beta production(GO:0071636) |
0.1 | 0.1 | GO:0045780 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.1 | 0.4 | GO:0007530 | sex determination(GO:0007530) |
0.1 | 0.1 | GO:0032782 | canalicular bile acid transport(GO:0015722) bile acid secretion(GO:0032782) |
0.1 | 0.4 | GO:0021675 | nerve development(GO:0021675) |
0.1 | 0.3 | GO:0021697 | cerebellar cortex formation(GO:0021697) |
0.1 | 0.1 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.1 | 0.1 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.1 | 0.4 | GO:0001832 | blastocyst growth(GO:0001832) |
0.1 | 0.4 | GO:0034130 | toll-like receptor 1 signaling pathway(GO:0034130) toll-like receptor 2 signaling pathway(GO:0034134) |
0.1 | 1.2 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 0.1 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.1 | 0.1 | GO:0006458 | 'de novo' protein folding(GO:0006458) |
0.1 | 1.3 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.1 | 0.3 | GO:0018216 | peptidyl-arginine methylation(GO:0018216) |
0.1 | 1.2 | GO:0009309 | amine biosynthetic process(GO:0009309) |
0.1 | 1.0 | GO:0010458 | exit from mitosis(GO:0010458) |
0.1 | 1.2 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.1 | 0.8 | GO:0009303 | rRNA transcription(GO:0009303) |
0.1 | 0.7 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.1 | 0.6 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.1 | 0.1 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.1 | 0.1 | GO:0016445 | somatic diversification of immunoglobulins(GO:0016445) |
0.1 | 4.6 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
0.1 | 0.3 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
0.1 | 0.9 | GO:0048011 | neurotrophin signaling pathway(GO:0038179) neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.1 | 0.8 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.1 | 0.8 | GO:0045667 | regulation of osteoblast differentiation(GO:0045667) |
0.1 | 0.8 | GO:0000718 | nucleotide-excision repair, DNA damage removal(GO:0000718) DNA excision(GO:0044349) |
0.1 | 0.1 | GO:0007260 | tyrosine phosphorylation of STAT protein(GO:0007260) |
0.1 | 1.5 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.1 | 0.6 | GO:0008595 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.1 | 5.9 | GO:0008033 | tRNA processing(GO:0008033) |
0.1 | 1.0 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.1 | 2.0 | GO:0031047 | gene silencing by RNA(GO:0031047) |
0.1 | 0.4 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.1 | 0.3 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 4.9 | GO:0000087 | mitotic M phase(GO:0000087) |
0.1 | 0.3 | GO:0043441 | acetoacetic acid biosynthetic process(GO:0043441) |
0.1 | 9.7 | GO:0000082 | G1/S transition of mitotic cell cycle(GO:0000082) cell cycle G1/S phase transition(GO:0044843) |
0.1 | 0.2 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.1 | 0.4 | GO:0009070 | serine family amino acid biosynthetic process(GO:0009070) |
0.1 | 0.6 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
0.1 | 1.6 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.1 | 0.5 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.1 | 0.6 | GO:0070588 | calcium ion transmembrane transport(GO:0070588) |
0.1 | 0.1 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.1 | 1.2 | GO:0035966 | response to unfolded protein(GO:0006986) response to topologically incorrect protein(GO:0035966) |
0.1 | 0.4 | GO:0001757 | somite specification(GO:0001757) |
0.1 | 0.1 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.1 | 1.0 | GO:0045930 | negative regulation of mitotic cell cycle(GO:0045930) |
0.1 | 0.4 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.1 | 0.2 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.1 | 0.2 | GO:1903115 | regulation of muscle filament sliding(GO:0032971) regulation of actin filament-based movement(GO:1903115) |
0.1 | 0.9 | GO:0002088 | lens development in camera-type eye(GO:0002088) |
0.1 | 0.2 | GO:0051298 | centrosome duplication(GO:0051298) |
0.1 | 0.1 | GO:0043954 | cellular component maintenance(GO:0043954) |
0.1 | 0.6 | GO:0044275 | cellular carbohydrate catabolic process(GO:0044275) |
0.1 | 0.5 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.1 | 0.5 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
0.1 | 0.6 | GO:0046320 | regulation of fatty acid oxidation(GO:0046320) |
0.1 | 1.5 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.1 | 0.1 | GO:0016571 | histone methylation(GO:0016571) |
0.1 | 0.7 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.1 | 0.1 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.1 | 0.1 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.1 | 0.2 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.1 | 0.2 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.1 | 0.9 | GO:0007219 | Notch signaling pathway(GO:0007219) |
0.1 | 1.2 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 0.2 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.1 | 0.6 | GO:1901998 | tetracycline transport(GO:0015904) antibiotic transport(GO:0042891) toxin transport(GO:1901998) |
0.1 | 0.1 | GO:2000106 | regulation of leukocyte apoptotic process(GO:2000106) |
0.1 | 4.3 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.1 | 0.8 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.1 | 5.0 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.1 | 0.4 | GO:0006862 | nucleotide transport(GO:0006862) |
0.1 | 1.0 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.1 | GO:0001702 | gastrulation with mouth forming second(GO:0001702) |
0.1 | 1.2 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.1 | 0.2 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.1 | 0.4 | GO:0034214 | protein hexamerization(GO:0034214) |
0.1 | 0.4 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.1 | 3.9 | GO:0007034 | vacuolar transport(GO:0007034) |
0.1 | 0.3 | GO:0032368 | regulation of lipid transport(GO:0032368) |
0.1 | 0.1 | GO:0006560 | proline metabolic process(GO:0006560) proline catabolic process(GO:0006562) |
0.1 | 0.3 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 2.8 | GO:0007265 | Ras protein signal transduction(GO:0007265) |
0.1 | 8.9 | GO:0016032 | viral process(GO:0016032) |
0.1 | 1.1 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.1 | 0.2 | GO:0021854 | hypothalamus development(GO:0021854) |
0.1 | 2.9 | GO:0019932 | second-messenger-mediated signaling(GO:0019932) |
0.1 | 0.3 | GO:0021766 | hippocampus development(GO:0021766) |
0.1 | 0.1 | GO:0045423 | regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.1 | 1.4 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
0.1 | 0.5 | GO:0006553 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
0.1 | 0.2 | GO:1903037 | regulation of T cell activation(GO:0050863) regulation of leukocyte cell-cell adhesion(GO:1903037) |
0.1 | 0.3 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.1 | 0.3 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.1 | 0.3 | GO:0035581 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.1 | 0.6 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.1 | 1.3 | GO:0009311 | oligosaccharide metabolic process(GO:0009311) |
0.1 | 0.2 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.1 | 0.2 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.1 | 0.1 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
0.1 | 0.2 | GO:0043030 | regulation of macrophage activation(GO:0043030) |
0.1 | 0.1 | GO:0051354 | negative regulation of oxidoreductase activity(GO:0051354) |
0.1 | 2.1 | GO:0022900 | electron transport chain(GO:0022900) |
0.1 | 0.2 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.1 | 1.8 | GO:0031023 | microtubule organizing center organization(GO:0031023) |
0.1 | 0.2 | GO:0043501 | skeletal muscle adaptation(GO:0043501) |
0.1 | 3.6 | GO:0006486 | protein glycosylation(GO:0006486) macromolecule glycosylation(GO:0043413) glycosylation(GO:0070085) |
0.1 | 0.1 | GO:0060349 | bone morphogenesis(GO:0060349) |
0.1 | 0.5 | GO:0006026 | aminoglycan catabolic process(GO:0006026) |
0.1 | 0.1 | GO:0048263 | determination of dorsal identity(GO:0048263) |
0.1 | 0.1 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.1 | 0.6 | GO:0042044 | water transport(GO:0006833) fluid transport(GO:0042044) |
0.1 | 0.4 | GO:0042475 | odontogenesis of dentin-containing tooth(GO:0042475) |
0.1 | 0.2 | GO:0016559 | peroxisome fission(GO:0016559) |
0.1 | 0.1 | GO:0015802 | basic amino acid transport(GO:0015802) |
0.1 | 0.1 | GO:0042026 | protein refolding(GO:0042026) |
0.1 | 0.2 | GO:0007567 | parturition(GO:0007567) |
0.1 | 0.4 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.1 | 0.5 | GO:0032635 | interleukin-6 production(GO:0032635) |
0.1 | 0.1 | GO:0051608 | histamine transport(GO:0051608) |
0.1 | 2.0 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.1 | 0.2 | GO:0042269 | regulation of natural killer cell mediated immunity(GO:0002715) regulation of natural killer cell mediated cytotoxicity(GO:0042269) |
0.1 | 0.3 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.1 | 1.4 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.1 | 0.8 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.1 | 0.2 | GO:0007512 | adult heart development(GO:0007512) |
0.1 | 0.2 | GO:0006261 | DNA-dependent DNA replication(GO:0006261) |
0.1 | 7.6 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
0.1 | 15.6 | GO:0006955 | immune response(GO:0006955) |
0.1 | 3.8 | GO:0006959 | humoral immune response(GO:0006959) |
0.1 | 2.4 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.1 | 5.4 | GO:0034728 | nucleosome organization(GO:0034728) |
0.1 | 0.3 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.1 | 0.2 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.1 | 0.2 | GO:0035121 | obsolete tail morphogenesis(GO:0035121) |
0.1 | 0.4 | GO:0042987 | amyloid precursor protein catabolic process(GO:0042987) |
0.1 | 0.7 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.1 | 0.6 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.1 | 0.2 | GO:0060526 | prostate glandular acinus development(GO:0060525) prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.1 | 0.1 | GO:0044764 | multi-organism cellular process(GO:0044764) |
0.1 | 0.3 | GO:0032204 | regulation of telomere maintenance(GO:0032204) |
0.1 | 0.3 | GO:0009191 | nucleoside diphosphate catabolic process(GO:0009134) ribonucleoside diphosphate catabolic process(GO:0009191) |
0.1 | 0.1 | GO:0051904 | melanosome transport(GO:0032402) pigment granule transport(GO:0051904) |
0.1 | 1.3 | GO:0051402 | neuron apoptotic process(GO:0051402) |
0.1 | 0.2 | GO:0072079 | nephron tubule formation(GO:0072079) |
0.1 | 10.2 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.1 | 0.1 | GO:0048617 | embryonic foregut morphogenesis(GO:0048617) |
0.1 | 0.4 | GO:0055007 | cardiac muscle cell differentiation(GO:0055007) |
0.1 | 0.1 | GO:0030916 | otic vesicle formation(GO:0030916) otic vesicle development(GO:0071599) otic vesicle morphogenesis(GO:0071600) |
0.1 | 0.2 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.1 | 25.5 | GO:0043043 | peptide biosynthetic process(GO:0043043) |
0.1 | 12.3 | GO:0051056 | regulation of small GTPase mediated signal transduction(GO:0051056) |
0.1 | 0.4 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.1 | 0.3 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 1.9 | GO:0006112 | energy reserve metabolic process(GO:0006112) |
0.1 | 0.2 | GO:0045768 | obsolete positive regulation of anti-apoptosis(GO:0045768) |
0.1 | 0.5 | GO:0009268 | response to pH(GO:0009268) |
0.1 | 0.3 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.1 | 2.1 | GO:0006310 | DNA recombination(GO:0006310) |
0.1 | 1.7 | GO:0006641 | triglyceride metabolic process(GO:0006641) |
0.1 | 0.1 | GO:0021533 | cell differentiation in hindbrain(GO:0021533) |
0.1 | 0.2 | GO:0051917 | regulation of fibrinolysis(GO:0051917) |
0.1 | 0.4 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.1 | 0.5 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
0.1 | 2.6 | GO:0006260 | DNA replication(GO:0006260) |
0.1 | 0.2 | GO:0042129 | regulation of T cell proliferation(GO:0042129) |
0.1 | 0.2 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.1 | 0.3 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 0.1 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
0.1 | 0.8 | GO:0031018 | endocrine pancreas development(GO:0031018) |
0.1 | 0.7 | GO:0046785 | microtubule polymerization(GO:0046785) |
0.1 | 0.2 | GO:0006040 | amino sugar metabolic process(GO:0006040) |
0.1 | 0.1 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.1 | 0.5 | GO:0015695 | organic cation transport(GO:0015695) |
0.1 | 3.8 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.1 | 1.2 | GO:0006612 | protein targeting to membrane(GO:0006612) |
0.1 | 1.1 | GO:0007126 | meiotic nuclear division(GO:0007126) |
0.1 | 0.2 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 0.2 | GO:0015838 | quaternary ammonium group transport(GO:0015697) amino-acid betaine transport(GO:0015838) carnitine transport(GO:0015879) |
0.1 | 0.1 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.1 | 0.2 | GO:0008105 | asymmetric protein localization(GO:0008105) |
0.1 | 0.1 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
0.1 | 1.3 | GO:0051925 | obsolete regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051925) |
0.1 | 0.1 | GO:0006907 | pinocytosis(GO:0006907) |
0.1 | 0.2 | GO:0021548 | pons development(GO:0021548) |
0.1 | 0.3 | GO:0006997 | nucleus organization(GO:0006997) |
0.1 | 0.1 | GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
0.1 | 0.2 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.1 | 2.8 | GO:0009615 | response to virus(GO:0009615) |
0.1 | 1.9 | GO:0006914 | autophagy(GO:0006914) |
0.1 | 0.1 | GO:0060013 | righting reflex(GO:0060013) |
0.1 | 0.1 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
0.1 | 6.0 | GO:0044419 | interspecies interaction between organisms(GO:0044419) |
0.1 | 0.1 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 0.6 | GO:0006302 | double-strand break repair(GO:0006302) |
0.1 | 6.0 | GO:0006814 | sodium ion transport(GO:0006814) |
0.1 | 0.4 | GO:0035967 | cellular response to topologically incorrect protein(GO:0035967) |
0.1 | 0.2 | GO:0018410 | C-terminal protein amino acid modification(GO:0018410) |
0.1 | 0.4 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.1 | 0.1 | GO:0045010 | actin nucleation(GO:0045010) |
0.1 | 2.6 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.1 | 0.8 | GO:0007281 | germ cell development(GO:0007281) |
0.1 | 4.2 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.1 | 0.3 | GO:0014047 | glutamate secretion(GO:0014047) |
0.1 | 0.3 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.1 | 0.2 | GO:0019236 | response to pheromone(GO:0019236) |
0.1 | 0.2 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 0.5 | GO:0030307 | positive regulation of cell growth(GO:0030307) |
0.1 | 0.3 | GO:0048753 | pigment granule organization(GO:0048753) |
0.1 | 0.3 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) |
0.1 | 1.1 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.1 | 2.4 | GO:0016071 | mRNA metabolic process(GO:0016071) |
0.1 | 0.1 | GO:0009067 | aspartate family amino acid biosynthetic process(GO:0009067) |
0.1 | 0.7 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.1 | 0.3 | GO:0046039 | GTP metabolic process(GO:0046039) |
0.1 | 0.1 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.1 | 0.1 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
0.1 | 0.1 | GO:0001820 | serotonin secretion(GO:0001820) |
0.1 | 0.1 | GO:0042537 | benzene-containing compound metabolic process(GO:0042537) |
0.1 | 5.6 | GO:0016568 | chromatin modification(GO:0016568) |
0.1 | 0.3 | GO:0070489 | T cell activation(GO:0042110) leukocyte aggregation(GO:0070486) T cell aggregation(GO:0070489) lymphocyte aggregation(GO:0071593) |
0.1 | 0.1 | GO:0002228 | natural killer cell mediated immunity(GO:0002228) natural killer cell mediated cytotoxicity(GO:0042267) |
0.1 | 0.1 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.1 | 0.7 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 0.8 | GO:0042326 | negative regulation of phosphorylation(GO:0042326) |
0.1 | 0.2 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.1 | 0.1 | GO:0030104 | water homeostasis(GO:0030104) |
0.1 | 0.5 | GO:0006555 | methionine metabolic process(GO:0006555) |
0.1 | 0.2 | GO:0000723 | telomere maintenance(GO:0000723) |
0.1 | 0.5 | GO:0007632 | visual behavior(GO:0007632) |
0.1 | 0.1 | GO:0032611 | interleukin-1 beta production(GO:0032611) interleukin-1 production(GO:0032612) |
0.1 | 0.2 | GO:0007215 | glutamate receptor signaling pathway(GO:0007215) |
0.1 | 0.1 | GO:0031334 | positive regulation of protein complex assembly(GO:0031334) |
0.1 | 0.3 | GO:0030183 | B cell differentiation(GO:0030183) |
0.1 | 0.2 | GO:0006301 | postreplication repair(GO:0006301) |
0.1 | 0.3 | GO:0030534 | adult behavior(GO:0030534) |
0.1 | 0.4 | GO:0060678 | dichotomous subdivision of terminal units involved in ureteric bud branching(GO:0060678) |
0.1 | 0.3 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.1 | 0.1 | GO:0050706 | regulation of interleukin-1 beta secretion(GO:0050706) |
0.1 | 0.5 | GO:0019319 | hexose biosynthetic process(GO:0019319) |
0.1 | 0.8 | GO:0008286 | insulin receptor signaling pathway(GO:0008286) |
0.1 | 0.1 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.1 | 0.1 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
0.1 | 0.4 | GO:1904029 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) regulation of cyclin-dependent protein kinase activity(GO:1904029) |
0.1 | 0.2 | GO:0006390 | mitochondrial RNA metabolic process(GO:0000959) transcription from mitochondrial promoter(GO:0006390) |
0.1 | 0.1 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.1 | 0.1 | GO:0006479 | protein methylation(GO:0006479) protein alkylation(GO:0008213) |
0.1 | 0.5 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.1 | 0.1 | GO:0006972 | hyperosmotic response(GO:0006972) |
0.1 | 0.1 | GO:0031000 | response to caffeine(GO:0031000) |
0.1 | 0.5 | GO:0051149 | positive regulation of muscle cell differentiation(GO:0051149) |
0.1 | 0.6 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.1 | 0.1 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.0 | 0.0 | GO:0002021 | response to dietary excess(GO:0002021) |
0.0 | 0.0 | GO:0043271 | negative regulation of ion transport(GO:0043271) |
0.0 | 0.1 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.0 | 0.1 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.0 | 0.5 | GO:0043269 | regulation of ion transport(GO:0043269) |
0.0 | 1.0 | GO:0061025 | membrane fusion(GO:0061025) |
0.0 | 0.1 | GO:0001906 | cell killing(GO:0001906) |
0.0 | 0.0 | GO:0033108 | mitochondrial respiratory chain complex assembly(GO:0033108) |
0.0 | 0.1 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.0 | 0.1 | GO:0002685 | regulation of leukocyte migration(GO:0002685) |
0.0 | 0.4 | GO:0009408 | response to heat(GO:0009408) |
0.0 | 0.1 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
0.0 | 0.0 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.0 | 0.2 | GO:0045666 | positive regulation of neuron differentiation(GO:0045666) |
0.0 | 0.3 | GO:0010212 | response to ionizing radiation(GO:0010212) |
0.0 | 0.2 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.0 | 0.4 | GO:0043687 | post-translational protein modification(GO:0043687) |
0.0 | 6.4 | GO:0007186 | G-protein coupled receptor signaling pathway(GO:0007186) |
0.0 | 0.0 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.0 | 0.0 | GO:0015810 | C4-dicarboxylate transport(GO:0015740) aspartate transport(GO:0015810) |
0.0 | 0.2 | GO:0006882 | cellular zinc ion homeostasis(GO:0006882) zinc ion homeostasis(GO:0055069) |
0.0 | 0.1 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.0 | 0.0 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.0 | 0.1 | GO:0046101 | hypoxanthine biosynthetic process(GO:0046101) |
0.0 | 0.1 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.0 | 0.2 | GO:0019359 | nicotinamide nucleotide biosynthetic process(GO:0019359) |
0.0 | 0.1 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.0 | 2.8 | GO:0051603 | proteolysis involved in cellular protein catabolic process(GO:0051603) |
0.0 | 0.1 | GO:0030279 | negative regulation of ossification(GO:0030279) |
0.0 | 0.2 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
0.0 | 0.1 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.0 | 0.8 | GO:0007204 | positive regulation of cytosolic calcium ion concentration(GO:0007204) |
0.0 | 0.1 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.0 | 0.1 | GO:0048588 | developmental cell growth(GO:0048588) |
0.0 | 0.1 | GO:0043248 | proteasome assembly(GO:0043248) |
0.0 | 0.0 | GO:1902692 | regulation of neuroblast proliferation(GO:1902692) |
0.0 | 0.2 | GO:0071166 | ribonucleoprotein complex localization(GO:0071166) |
0.0 | 0.1 | GO:0070989 | oxidative demethylation(GO:0070989) |
0.0 | 10.9 | GO:0015031 | protein transport(GO:0015031) |
0.0 | 0.1 | GO:0042737 | drug catabolic process(GO:0042737) |
0.0 | 0.1 | GO:0051310 | mitotic metaphase plate congression(GO:0007080) metaphase plate congression(GO:0051310) |
0.0 | 34.3 | GO:0016070 | RNA metabolic process(GO:0016070) |
0.0 | 0.2 | GO:0045995 | regulation of embryonic development(GO:0045995) |
0.0 | 0.1 | GO:0044245 | polysaccharide digestion(GO:0044245) |
0.0 | 0.0 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.0 | 0.2 | GO:0048863 | stem cell differentiation(GO:0048863) |
0.0 | 0.5 | GO:0008643 | carbohydrate transport(GO:0008643) |
0.0 | 0.0 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
0.0 | 0.0 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.0 | 0.0 | GO:0001660 | fever generation(GO:0001660) |
0.0 | 0.0 | GO:0016045 | detection of bacterium(GO:0016045) |
0.0 | 0.1 | GO:0009953 | dorsal/ventral pattern formation(GO:0009953) |
0.0 | 0.1 | GO:0019695 | choline metabolic process(GO:0019695) |
0.0 | 0.0 | GO:0040023 | establishment of nucleus localization(GO:0040023) |
0.0 | 0.1 | GO:0060135 | maternal process involved in female pregnancy(GO:0060135) |
0.0 | 0.0 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
0.0 | 0.0 | GO:1904894 | positive regulation of JAK-STAT cascade(GO:0046427) positive regulation of STAT cascade(GO:1904894) |
0.0 | 0.1 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.0 | 0.9 | GO:0006457 | protein folding(GO:0006457) |
0.0 | 0.1 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.0 | 0.0 | GO:0048385 | regulation of retinoic acid receptor signaling pathway(GO:0048385) |
0.0 | 4.2 | GO:0006508 | proteolysis(GO:0006508) |
0.0 | 0.0 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.0 | 4.9 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 0.6 | GO:0007018 | microtubule-based movement(GO:0007018) |
0.0 | 0.0 | GO:0006772 | thiamine metabolic process(GO:0006772) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 6.5 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
1.4 | 4.1 | GO:0044462 | external encapsulating structure part(GO:0044462) |
1.1 | 3.4 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
1.1 | 3.3 | GO:0032009 | early phagosome(GO:0032009) |
1.0 | 2.9 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
1.0 | 8.6 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.9 | 4.7 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.9 | 0.9 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.9 | 5.2 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.8 | 5.7 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.8 | 11.2 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.8 | 4.8 | GO:0005883 | neurofilament(GO:0005883) |
0.8 | 0.8 | GO:0005921 | gap junction(GO:0005921) |
0.8 | 3.1 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.8 | 0.8 | GO:0043235 | receptor complex(GO:0043235) |
0.8 | 3.1 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
0.7 | 2.2 | GO:0072487 | MSL complex(GO:0072487) |
0.7 | 2.2 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.7 | 7.2 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.7 | 5.7 | GO:0005861 | troponin complex(GO:0005861) |
0.7 | 2.1 | GO:0070820 | tertiary granule(GO:0070820) |
0.7 | 0.7 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.7 | 2.7 | GO:0005667 | transcription factor complex(GO:0005667) |
0.7 | 4.7 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.6 | 3.2 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.6 | 1.9 | GO:0048475 | membrane coat(GO:0030117) coated membrane(GO:0048475) |
0.6 | 0.6 | GO:0031090 | organelle membrane(GO:0031090) |
0.6 | 4.4 | GO:0098984 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.6 | 2.5 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.6 | 1.3 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.6 | 0.6 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.6 | 2.3 | GO:0005827 | polar microtubule(GO:0005827) |
0.6 | 1.7 | GO:0031904 | endosome lumen(GO:0031904) |
0.6 | 3.4 | GO:0001891 | phagocytic cup(GO:0001891) |
0.6 | 6.2 | GO:0001772 | immunological synapse(GO:0001772) |
0.6 | 2.2 | GO:0043218 | compact myelin(GO:0043218) |
0.5 | 1.6 | GO:0031313 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.5 | 2.2 | GO:0005638 | lamin filament(GO:0005638) |
0.5 | 4.8 | GO:0043209 | myelin sheath(GO:0043209) |
0.5 | 4.8 | GO:0000109 | nucleotide-excision repair complex(GO:0000109) |
0.5 | 0.5 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.5 | 1.0 | GO:0031932 | TORC2 complex(GO:0031932) |
0.5 | 10.8 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.5 | 3.1 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.5 | 1.0 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.5 | 2.5 | GO:0005694 | chromosome(GO:0005694) |
0.5 | 1.0 | GO:0032059 | bleb(GO:0032059) |
0.5 | 1.5 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.5 | 1.4 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.5 | 3.4 | GO:0034451 | centriolar satellite(GO:0034451) |
0.5 | 3.8 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.5 | 5.2 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.5 | 3.3 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.5 | 1.4 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.5 | 1.4 | GO:0016939 | kinesin II complex(GO:0016939) |
0.4 | 9.2 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.4 | 1.7 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.4 | 1.2 | GO:0031501 | mannosyltransferase complex(GO:0031501) dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.4 | 6.8 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
0.4 | 2.4 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.4 | 1.2 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.4 | 0.4 | GO:0031430 | M band(GO:0031430) |
0.4 | 1.5 | GO:0070552 | BRISC complex(GO:0070552) |
0.4 | 2.2 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.4 | 0.4 | GO:0033643 | host(GO:0018995) host cell part(GO:0033643) host intracellular part(GO:0033646) intracellular region of host(GO:0043656) host cell(GO:0043657) other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.4 | 1.4 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.4 | 1.1 | GO:0001940 | male pronucleus(GO:0001940) |
0.4 | 0.4 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.3 | 1.4 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.3 | 1.4 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.3 | 2.4 | GO:0000346 | transcription export complex(GO:0000346) |
0.3 | 1.4 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.3 | 3.1 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.3 | 1.4 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.3 | 1.0 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.3 | 3.0 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.3 | 6.7 | GO:0031519 | PcG protein complex(GO:0031519) |
0.3 | 1.0 | GO:1903561 | extracellular exosome(GO:0070062) extracellular vesicle(GO:1903561) |
0.3 | 2.0 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.3 | 1.0 | GO:0000124 | SAGA complex(GO:0000124) |
0.3 | 2.0 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.3 | 0.3 | GO:0005839 | proteasome core complex(GO:0005839) |
0.3 | 1.0 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.3 | 0.3 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.3 | 4.4 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.3 | 3.1 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.3 | 2.2 | GO:0005916 | fascia adherens(GO:0005916) |
0.3 | 2.8 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.3 | 1.2 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.3 | 1.5 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.3 | 1.5 | GO:0032590 | dendrite membrane(GO:0032590) |
0.3 | 5.8 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.3 | 0.6 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.3 | 0.9 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.3 | 1.5 | GO:0000791 | euchromatin(GO:0000791) |
0.3 | 0.9 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.3 | 7.3 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.3 | 2.9 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.3 | 1.7 | GO:0042382 | paraspeckles(GO:0042382) |
0.3 | 2.0 | GO:0031256 | leading edge membrane(GO:0031256) |
0.3 | 23.5 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.3 | 4.8 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.3 | 2.3 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.3 | 0.8 | GO:0034464 | BBSome(GO:0034464) |
0.3 | 0.6 | GO:0030897 | HOPS complex(GO:0030897) |
0.3 | 4.5 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.3 | 9.2 | GO:0030175 | filopodium(GO:0030175) |
0.3 | 0.8 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.3 | 5.8 | GO:0005776 | autophagosome(GO:0005776) |
0.3 | 31.7 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.3 | 1.4 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.3 | 4.6 | GO:0005844 | polysome(GO:0005844) |
0.3 | 5.7 | GO:0032155 | cell division site(GO:0032153) cell division site part(GO:0032155) |
0.3 | 1.1 | GO:0016589 | NURF complex(GO:0016589) |
0.3 | 1.1 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.3 | 3.7 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.3 | 0.5 | GO:0044291 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.3 | 2.1 | GO:0005884 | actin filament(GO:0005884) |
0.3 | 1.8 | GO:0030681 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.3 | 0.8 | GO:0000299 | obsolete integral to membrane of membrane fraction(GO:0000299) |
0.3 | 1.3 | GO:0042588 | zymogen granule(GO:0042588) |
0.3 | 1.8 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.3 | 0.5 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.3 | 1.8 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.3 | 1.3 | GO:0030315 | T-tubule(GO:0030315) |
0.3 | 1.5 | GO:0070822 | Sin3 complex(GO:0016580) Sin3-type complex(GO:0070822) |
0.3 | 5.0 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.2 | 15.7 | GO:0030027 | lamellipodium(GO:0030027) |
0.2 | 3.2 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.2 | 2.0 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.2 | 0.5 | GO:0005792 | obsolete microsome(GO:0005792) |
0.2 | 1.5 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.2 | 1.7 | GO:0042598 | obsolete vesicular fraction(GO:0042598) |
0.2 | 0.7 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.2 | 0.5 | GO:0042584 | chromaffin granule(GO:0042583) chromaffin granule membrane(GO:0042584) |
0.2 | 1.4 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.2 | 0.5 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.2 | 1.7 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.2 | 10.2 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.2 | 12.8 | GO:0005643 | nuclear pore(GO:0005643) |
0.2 | 0.7 | GO:0071986 | Ragulator complex(GO:0071986) |
0.2 | 7.7 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.2 | 0.5 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.2 | 0.2 | GO:0000407 | pre-autophagosomal structure(GO:0000407) pre-autophagosomal structure membrane(GO:0034045) |
0.2 | 1.4 | GO:0061200 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
0.2 | 0.5 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.2 | 0.2 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.2 | 1.8 | GO:0000242 | pericentriolar material(GO:0000242) |
0.2 | 3.9 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.2 | 1.4 | GO:0044304 | main axon(GO:0044304) |
0.2 | 0.9 | GO:0097526 | U4/U6 x U5 tri-snRNP complex(GO:0046540) spliceosomal tri-snRNP complex(GO:0097526) |
0.2 | 0.4 | GO:0002139 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.2 | 2.9 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.2 | 1.9 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.2 | 0.6 | GO:0031083 | BLOC complex(GO:0031082) BLOC-1 complex(GO:0031083) |
0.2 | 0.4 | GO:0000800 | lateral element(GO:0000800) |
0.2 | 0.6 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.2 | 6.2 | GO:0005876 | spindle microtubule(GO:0005876) |
0.2 | 1.7 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.2 | 1.0 | GO:0045179 | apical cortex(GO:0045179) |
0.2 | 10.2 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.2 | 0.8 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.2 | 10.4 | GO:0012506 | vesicle membrane(GO:0012506) |
0.2 | 2.3 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.2 | 0.6 | GO:0045298 | tubulin complex(GO:0045298) |
0.2 | 1.9 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.2 | 0.8 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.2 | 0.6 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.2 | 3.4 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.2 | 1.0 | GO:0000805 | X chromosome(GO:0000805) |
0.2 | 2.0 | GO:0071203 | WASH complex(GO:0071203) |
0.2 | 0.6 | GO:0031528 | microvillus membrane(GO:0031528) |
0.2 | 2.0 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.2 | 0.2 | GO:0033270 | paranode region of axon(GO:0033270) |
0.2 | 5.3 | GO:0031902 | late endosome membrane(GO:0031902) |
0.2 | 7.3 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.2 | 3.5 | GO:0000502 | proteasome complex(GO:0000502) |
0.2 | 1.2 | GO:0005683 | U7 snRNP(GO:0005683) |
0.2 | 1.1 | GO:0051233 | spindle midzone(GO:0051233) |
0.2 | 0.8 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.2 | 9.3 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.2 | 0.9 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.2 | 0.4 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.2 | 0.9 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.2 | 2.6 | GO:0043195 | terminal bouton(GO:0043195) |
0.2 | 0.6 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.2 | 0.4 | GO:0001950 | obsolete plasma membrane enriched fraction(GO:0001950) |
0.2 | 17.0 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.2 | 2.8 | GO:0008305 | integrin complex(GO:0008305) protein complex involved in cell adhesion(GO:0098636) |
0.2 | 5.4 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.2 | 1.1 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.2 | 0.7 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.2 | 0.7 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.2 | 2.7 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.2 | 1.8 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.2 | 2.9 | GO:0032420 | stereocilium(GO:0032420) |
0.2 | 2.9 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.2 | 0.7 | GO:0032156 | septin complex(GO:0031105) septin cytoskeleton(GO:0032156) |
0.2 | 6.9 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.2 | 0.9 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.2 | 3.0 | GO:0035097 | methyltransferase complex(GO:0034708) histone methyltransferase complex(GO:0035097) |
0.2 | 0.5 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.2 | 4.3 | GO:0005626 | obsolete insoluble fraction(GO:0005626) |
0.2 | 1.9 | GO:0098802 | plasma membrane receptor complex(GO:0098802) |
0.2 | 1.4 | GO:0070652 | HAUS complex(GO:0070652) |
0.2 | 4.1 | GO:0031526 | brush border membrane(GO:0031526) |
0.2 | 0.7 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.2 | 0.2 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.2 | 11.4 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.2 | 0.3 | GO:0030904 | retromer complex(GO:0030904) |
0.2 | 13.8 | GO:0005819 | spindle(GO:0005819) |
0.2 | 3.5 | GO:0032587 | ruffle membrane(GO:0032587) |
0.2 | 15.1 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.2 | 0.3 | GO:0031931 | TORC1 complex(GO:0031931) |
0.2 | 0.5 | GO:0070188 | obsolete Stn1-Ten1 complex(GO:0070188) |
0.2 | 1.8 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.2 | 0.8 | GO:0030426 | growth cone(GO:0030426) site of polarized growth(GO:0030427) |
0.2 | 1.9 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.2 | 2.9 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
0.2 | 2.2 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.2 | 0.6 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.2 | 0.3 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.2 | 37.6 | GO:0005768 | endosome(GO:0005768) |
0.2 | 29.2 | GO:0005625 | obsolete soluble fraction(GO:0005625) |
0.2 | 0.8 | GO:0000796 | condensin complex(GO:0000796) |
0.2 | 0.5 | GO:0005915 | zonula adherens(GO:0005915) |
0.2 | 2.1 | GO:0046930 | pore complex(GO:0046930) |
0.2 | 0.3 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.2 | 0.8 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 0.1 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 1.9 | GO:0070461 | SAGA-type complex(GO:0070461) |
0.1 | 9.0 | GO:0019717 | obsolete synaptosome(GO:0019717) |
0.1 | 0.7 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.1 | 0.4 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 4.5 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 0.6 | GO:0016585 | obsolete chromatin remodeling complex(GO:0016585) |
0.1 | 0.4 | GO:0042825 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
0.1 | 1.0 | GO:0005840 | ribosome(GO:0005840) |
0.1 | 0.3 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 0.6 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 0.1 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 12.6 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 0.9 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 2.8 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.1 | 3.2 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.1 | 2.6 | GO:0044798 | nuclear transcription factor complex(GO:0044798) |
0.1 | 0.8 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 1.6 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.1 | 3.9 | GO:0000776 | kinetochore(GO:0000776) |
0.1 | 3.9 | GO:0036064 | ciliary basal body(GO:0036064) |
0.1 | 0.3 | GO:0042599 | lamellar body(GO:0042599) |
0.1 | 0.9 | GO:0042612 | MHC protein complex(GO:0042611) MHC class I protein complex(GO:0042612) |
0.1 | 1.4 | GO:0005814 | centriole(GO:0005814) |
0.1 | 0.6 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.1 | 0.5 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 515.4 | GO:0005634 | nucleus(GO:0005634) |
0.1 | 1.4 | GO:0019861 | obsolete flagellum(GO:0019861) |
0.1 | 0.9 | GO:0031201 | SNARE complex(GO:0031201) |
0.1 | 4.6 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.1 | 1.2 | GO:0031513 | nonmotile primary cilium(GO:0031513) |
0.1 | 1.1 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 7.8 | GO:0019867 | outer membrane(GO:0019867) |
0.1 | 3.1 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 60.6 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.1 | 1.5 | GO:0030018 | Z disc(GO:0030018) |
0.1 | 47.9 | GO:0005794 | Golgi apparatus(GO:0005794) |
0.1 | 3.3 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.1 | 73.9 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 0.1 | GO:0097458 | neuron part(GO:0097458) |
0.1 | 3.2 | GO:0030424 | axon(GO:0030424) |
0.1 | 4.8 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 0.1 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 1.4 | GO:0034358 | protein-lipid complex(GO:0032994) plasma lipoprotein particle(GO:0034358) lipoprotein particle(GO:1990777) |
0.1 | 2.2 | GO:0034707 | chloride channel complex(GO:0034707) |
0.1 | 65.9 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.1 | 2.0 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.1 | 0.3 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 0.1 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 0.3 | GO:0016234 | inclusion body(GO:0016234) |
0.1 | 0.5 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 0.8 | GO:1990904 | intracellular ribonucleoprotein complex(GO:0030529) ribonucleoprotein complex(GO:1990904) |
0.1 | 169.3 | GO:0016021 | integral component of membrane(GO:0016021) |
0.1 | 0.3 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.1 | 0.2 | GO:0033150 | cytoskeletal calyx(GO:0033150) |
0.1 | 37.9 | GO:0005829 | cytosol(GO:0005829) |
0.1 | 0.1 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.1 | 0.1 | GO:0042581 | specific granule(GO:0042581) |
0.1 | 0.1 | GO:0030496 | midbody(GO:0030496) |
0.1 | 0.3 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.1 | 1.0 | GO:0005929 | cilium(GO:0005929) |
0.0 | 0.2 | GO:0001726 | ruffle(GO:0001726) |
0.0 | 0.8 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.0 | 0.3 | GO:0043005 | neuron projection(GO:0043005) |
0.0 | 0.0 | GO:0033011 | perinuclear theca(GO:0033011) |
0.0 | 0.1 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.0 | 0.1 | GO:0031982 | vesicle(GO:0031982) |
0.0 | 0.0 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.0 | 0.0 | GO:0070695 | FHF complex(GO:0070695) |
0.0 | 4.8 | GO:0005886 | plasma membrane(GO:0005886) |
0.0 | 0.1 | GO:0097223 | sperm part(GO:0097223) |
0.0 | 21.1 | GO:0005622 | intracellular(GO:0005622) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 5.0 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
1.7 | 5.0 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
1.5 | 6.1 | GO:0031014 | troponin T binding(GO:0031014) |
1.5 | 4.4 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
1.5 | 17.4 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) |
1.4 | 4.2 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
1.4 | 4.1 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
1.2 | 6.0 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
1.2 | 4.8 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
1.1 | 6.8 | GO:0001727 | lipid kinase activity(GO:0001727) |
1.1 | 1.1 | GO:0033691 | sialic acid binding(GO:0033691) |
1.1 | 8.7 | GO:0050700 | CARD domain binding(GO:0050700) |
1.0 | 3.1 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
1.0 | 3.1 | GO:0004476 | mannose-6-phosphate isomerase activity(GO:0004476) |
1.0 | 3.1 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
1.0 | 3.0 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
1.0 | 4.0 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
1.0 | 2.9 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
1.0 | 1.9 | GO:0052659 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity(GO:0052659) |
0.9 | 2.8 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.9 | 3.8 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.9 | 2.8 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.9 | 2.8 | GO:0035197 | siRNA binding(GO:0035197) |
0.9 | 5.4 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.9 | 2.7 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.9 | 5.4 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.9 | 4.4 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.9 | 2.6 | GO:0050693 | LBD domain binding(GO:0050693) |
0.9 | 2.6 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.9 | 0.9 | GO:0046030 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) inositol trisphosphate phosphatase activity(GO:0046030) |
0.9 | 3.4 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.8 | 3.4 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.8 | 6.7 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.8 | 8.4 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.8 | 2.5 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.8 | 13.7 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.8 | 6.4 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.8 | 3.1 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.8 | 0.8 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.7 | 4.5 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.7 | 3.7 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.7 | 1.5 | GO:0000247 | C-8 sterol isomerase activity(GO:0000247) |
0.7 | 5.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.7 | 1.4 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.7 | 2.9 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.7 | 4.3 | GO:0016208 | AMP binding(GO:0016208) |
0.7 | 2.1 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.7 | 4.8 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.7 | 2.7 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) |
0.7 | 2.0 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.7 | 4.6 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.7 | 3.3 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.7 | 2.6 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.7 | 3.3 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.7 | 2.0 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.7 | 1.3 | GO:0005123 | death receptor binding(GO:0005123) |
0.6 | 7.8 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.6 | 5.8 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.6 | 2.6 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.6 | 22.9 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.6 | 2.5 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.6 | 1.9 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.6 | 6.3 | GO:0003709 | obsolete RNA polymerase III transcription factor activity(GO:0003709) |
0.6 | 1.9 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.6 | 1.9 | GO:0005113 | patched binding(GO:0005113) |
0.6 | 1.9 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.6 | 3.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.6 | 1.2 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.6 | 1.2 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.6 | 4.3 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.6 | 2.4 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.6 | 1.8 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.6 | 0.6 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.6 | 1.2 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.6 | 1.8 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.6 | 1.2 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.6 | 2.9 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.6 | 2.9 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.6 | 1.7 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.6 | 1.7 | GO:0004500 | dopamine beta-monooxygenase activity(GO:0004500) |
0.6 | 6.3 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.6 | 5.7 | GO:0030276 | clathrin binding(GO:0030276) |
0.6 | 26.4 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.6 | 0.6 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.6 | 8.9 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.6 | 2.2 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.6 | 2.2 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.5 | 2.2 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.5 | 0.5 | GO:0005035 | death receptor activity(GO:0005035) |
0.5 | 2.2 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.5 | 4.4 | GO:0005522 | profilin binding(GO:0005522) |
0.5 | 8.7 | GO:0043621 | protein self-association(GO:0043621) |
0.5 | 2.7 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.5 | 3.3 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.5 | 1.6 | GO:0051425 | PTB domain binding(GO:0051425) |
0.5 | 2.7 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.5 | 2.7 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.5 | 1.6 | GO:0030343 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.5 | 2.6 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.5 | 1.6 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.5 | 3.1 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.5 | 0.5 | GO:0003896 | DNA primase activity(GO:0003896) |
0.5 | 1.0 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.5 | 2.1 | GO:0048495 | Roundabout binding(GO:0048495) |
0.5 | 6.2 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.5 | 1.0 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.5 | 0.5 | GO:0004516 | nicotinate phosphoribosyltransferase activity(GO:0004516) |
0.5 | 1.5 | GO:0055106 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.5 | 1.0 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.5 | 18.5 | GO:0001948 | glycoprotein binding(GO:0001948) |
0.5 | 2.0 | GO:0015925 | galactosidase activity(GO:0015925) |
0.5 | 2.5 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.5 | 2.0 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.5 | 9.8 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.5 | 5.8 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.5 | 2.9 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.5 | 1.4 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.5 | 4.3 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.5 | 8.5 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.5 | 1.4 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.5 | 1.4 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.5 | 2.3 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.5 | 1.4 | GO:0048156 | tau protein binding(GO:0048156) |
0.5 | 2.3 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.5 | 1.4 | GO:0043398 | HLH domain binding(GO:0043398) |
0.5 | 3.2 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.5 | 2.3 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.5 | 1.4 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.5 | 2.3 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.5 | 1.8 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.4 | 2.7 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.4 | 0.9 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.4 | 4.9 | GO:0030553 | cGMP binding(GO:0030553) |
0.4 | 1.3 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.4 | 1.3 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.4 | 1.3 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.4 | 3.1 | GO:0005112 | Notch binding(GO:0005112) |
0.4 | 7.9 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.4 | 1.3 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.4 | 1.7 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.4 | 1.3 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.4 | 5.6 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.4 | 1.3 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.4 | 0.4 | GO:0019902 | phosphatase binding(GO:0019902) |
0.4 | 2.5 | GO:0001012 | RNA polymerase II regulatory region sequence-specific DNA binding(GO:0000977) RNA polymerase II regulatory region DNA binding(GO:0001012) |
0.4 | 1.3 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.4 | 1.7 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.4 | 1.7 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.4 | 0.8 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.4 | 1.7 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
0.4 | 1.2 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.4 | 4.6 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.4 | 1.2 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.4 | 2.9 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.4 | 1.2 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.4 | 1.2 | GO:1990939 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) ATP-dependent microtubule motor activity(GO:1990939) |
0.4 | 2.5 | GO:0070513 | death domain binding(GO:0070513) |
0.4 | 1.2 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.4 | 1.2 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.4 | 4.1 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.4 | 1.6 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.4 | 1.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.4 | 4.8 | GO:0008556 | potassium-transporting ATPase activity(GO:0008556) |
0.4 | 1.2 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
0.4 | 2.8 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.4 | 2.4 | GO:0004950 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.4 | 2.0 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.4 | 2.4 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.4 | 0.4 | GO:0015205 | nucleobase transmembrane transporter activity(GO:0015205) |
0.4 | 1.6 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.4 | 1.9 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.4 | 1.6 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.4 | 1.6 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.4 | 1.6 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.4 | 0.8 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.4 | 5.0 | GO:0043499 | obsolete eukaryotic cell surface binding(GO:0043499) |
0.4 | 1.1 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.4 | 1.5 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.4 | 0.8 | GO:0019956 | chemokine binding(GO:0019956) |
0.4 | 1.1 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.4 | 1.1 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.4 | 0.4 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.4 | 1.9 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.4 | 3.0 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.4 | 1.1 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.4 | 2.2 | GO:0031432 | titin binding(GO:0031432) |
0.4 | 1.5 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) |
0.4 | 0.4 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
0.4 | 0.7 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.4 | 1.4 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.4 | 0.7 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.4 | 0.4 | GO:0001784 | phosphotyrosine binding(GO:0001784) protein phosphorylated amino acid binding(GO:0045309) |
0.4 | 1.8 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.4 | 1.8 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.4 | 0.7 | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding(GO:0000981) |
0.3 | 1.0 | GO:0004607 | phosphatidylcholine-sterol O-acyltransferase activity(GO:0004607) |
0.3 | 1.4 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.3 | 0.7 | GO:0034187 | obsolete apolipoprotein E binding(GO:0034187) |
0.3 | 1.0 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.3 | 0.7 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.3 | 1.0 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.3 | 4.7 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.3 | 1.0 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.3 | 1.0 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.3 | 0.7 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.3 | 2.0 | GO:0005521 | lamin binding(GO:0005521) |
0.3 | 7.0 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
0.3 | 1.7 | GO:0015288 | porin activity(GO:0015288) |
0.3 | 3.6 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.3 | 1.6 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.3 | 3.0 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
0.3 | 2.0 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.3 | 4.2 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.3 | 2.9 | GO:0050699 | WW domain binding(GO:0050699) |
0.3 | 2.6 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.3 | 7.8 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.3 | 0.3 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.3 | 1.0 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.3 | 1.9 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.3 | 0.3 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.3 | 1.9 | GO:0030507 | spectrin binding(GO:0030507) |
0.3 | 2.8 | GO:0030515 | snoRNA binding(GO:0030515) |
0.3 | 1.3 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.3 | 0.3 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.3 | 0.6 | GO:0003680 | AT DNA binding(GO:0003680) |
0.3 | 0.9 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.3 | 0.9 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.3 | 2.6 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.3 | 0.3 | GO:0043176 | amine binding(GO:0043176) |
0.3 | 2.6 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.3 | 0.9 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.3 | 0.6 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.3 | 2.0 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.3 | 2.3 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.3 | 2.9 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.3 | 1.7 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.3 | 0.9 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.3 | 1.1 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.3 | 0.3 | GO:0043028 | cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) |
0.3 | 1.4 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.3 | 1.1 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.3 | 4.2 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.3 | 0.8 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.3 | 0.8 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.3 | 1.9 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.3 | 1.4 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.3 | 4.2 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.3 | 1.9 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.3 | 1.4 | GO:0001848 | complement binding(GO:0001848) |
0.3 | 3.3 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.3 | 0.8 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.3 | 0.8 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.3 | 1.6 | GO:0030274 | LIM domain binding(GO:0030274) |
0.3 | 2.2 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.3 | 1.3 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.3 | 3.8 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.3 | 1.3 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.3 | 2.7 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.3 | 1.1 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.3 | 1.1 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.3 | 1.3 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.3 | 3.2 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.3 | 2.1 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.3 | 0.8 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.3 | 2.4 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
0.3 | 20.3 | GO:0003704 | obsolete specific RNA polymerase II transcription factor activity(GO:0003704) |
0.3 | 6.6 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.3 | 0.5 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.3 | 1.6 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.3 | 1.3 | GO:0004904 | interferon receptor activity(GO:0004904) |
0.3 | 1.3 | GO:0032451 | demethylase activity(GO:0032451) |
0.3 | 0.5 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.3 | 0.3 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.3 | 0.8 | GO:0008469 | histone-arginine N-methyltransferase activity(GO:0008469) |
0.3 | 0.3 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.3 | 4.9 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.3 | 3.8 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.3 | 0.5 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.3 | 0.5 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
0.3 | 1.5 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.3 | 0.5 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.3 | 0.3 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.3 | 1.3 | GO:0016986 | obsolete transcription initiation factor activity(GO:0016986) |
0.3 | 1.5 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.3 | 0.5 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.3 | 0.5 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.3 | 0.3 | GO:0046790 | virion binding(GO:0046790) |
0.3 | 1.8 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.2 | 0.7 | GO:0034452 | dynactin binding(GO:0034452) |
0.2 | 4.2 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.2 | 18.7 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.2 | 1.7 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
0.2 | 1.5 | GO:0008159 | obsolete positive transcription elongation factor activity(GO:0008159) |
0.2 | 1.5 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.2 | 0.5 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
0.2 | 5.1 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.2 | 2.9 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.2 | 0.7 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.2 | 0.2 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.2 | 0.7 | GO:0042156 | obsolete zinc-mediated transcriptional activator activity(GO:0042156) |
0.2 | 2.4 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.2 | 26.4 | GO:0003702 | obsolete RNA polymerase II transcription factor activity(GO:0003702) |
0.2 | 3.8 | GO:0051117 | ATPase binding(GO:0051117) |
0.2 | 0.2 | GO:0001099 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.2 | 1.7 | GO:0070717 | poly(A) binding(GO:0008143) poly-purine tract binding(GO:0070717) |
0.2 | 0.7 | GO:0004875 | complement receptor activity(GO:0004875) |
0.2 | 0.9 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.2 | 2.6 | GO:0004835 | tubulin-tyrosine ligase activity(GO:0004835) |
0.2 | 4.7 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.2 | 3.1 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.2 | 0.2 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
0.2 | 0.5 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.2 | 1.2 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.2 | 1.2 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.2 | 5.1 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.2 | 1.6 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.2 | 0.2 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.2 | 0.2 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
0.2 | 2.1 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.2 | 0.2 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.2 | 1.8 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.2 | 0.2 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.2 | 2.5 | GO:0002039 | p53 binding(GO:0002039) |
0.2 | 1.1 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.2 | 0.2 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.2 | 0.7 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.2 | 0.4 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.2 | 0.2 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.2 | 0.2 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.2 | 6.8 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.2 | 5.3 | GO:0019843 | rRNA binding(GO:0019843) |
0.2 | 1.3 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.2 | 2.0 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) |
0.2 | 1.1 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.2 | 2.4 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.2 | 0.4 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.2 | 2.8 | GO:0070888 | E-box binding(GO:0070888) |
0.2 | 0.2 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
0.2 | 0.7 | GO:0004802 | transketolase activity(GO:0004802) |
0.2 | 0.6 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.2 | 1.7 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.2 | 0.2 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.2 | 0.8 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.2 | 0.6 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.2 | 0.6 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.2 | 1.0 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.2 | 1.2 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.2 | 0.8 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.2 | 0.6 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.2 | 3.1 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.2 | 1.2 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.2 | 0.6 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.2 | 41.5 | GO:0016563 | obsolete transcription activator activity(GO:0016563) |
0.2 | 0.8 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.2 | 0.6 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.2 | 0.4 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.2 | 1.4 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.2 | 7.1 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
0.2 | 0.8 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.2 | 2.4 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.2 | 1.2 | GO:0003785 | actin monomer binding(GO:0003785) |
0.2 | 0.6 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) |
0.2 | 4.3 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.2 | 4.5 | GO:0019905 | syntaxin binding(GO:0019905) |
0.2 | 0.4 | GO:0042806 | fucose binding(GO:0042806) |
0.2 | 0.8 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.2 | 11.8 | GO:0051020 | GTPase binding(GO:0051020) |
0.2 | 1.4 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.2 | 1.7 | GO:0070403 | NAD+ binding(GO:0070403) |
0.2 | 0.6 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.2 | 1.5 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.2 | 1.9 | GO:0001619 | obsolete lysosphingolipid and lysophosphatidic acid receptor activity(GO:0001619) |
0.2 | 0.6 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.2 | 0.6 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.2 | 0.7 | GO:0004064 | arylesterase activity(GO:0004064) |
0.2 | 6.9 | GO:0008137 | NADH dehydrogenase activity(GO:0003954) NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.2 | 4.1 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.2 | 0.9 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.2 | 5.5 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.2 | 0.2 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.2 | 0.5 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.2 | 0.7 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.2 | 0.4 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.2 | 1.8 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.2 | 1.3 | GO:0034062 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.2 | 4.7 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.2 | 0.5 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.2 | 9.9 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.2 | 0.9 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.2 | 0.5 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.2 | 1.3 | GO:0000339 | RNA cap binding(GO:0000339) |
0.2 | 0.7 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.2 | 0.2 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
0.2 | 0.9 | GO:0005499 | vitamin D binding(GO:0005499) |
0.2 | 0.4 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.2 | 1.8 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.2 | 1.6 | GO:0019864 | IgG binding(GO:0019864) |
0.2 | 0.4 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.2 | 0.4 | GO:0035173 | histone kinase activity(GO:0035173) |
0.2 | 2.3 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.2 | 1.1 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.2 | 0.7 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.2 | 0.5 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.2 | 1.9 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.2 | 0.5 | GO:0019863 | IgE binding(GO:0019863) |
0.2 | 1.0 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.2 | 0.9 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.2 | 0.5 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.2 | 0.3 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.2 | 2.7 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.2 | 2.7 | GO:0019209 | kinase activator activity(GO:0019209) |
0.2 | 0.9 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.2 | 0.2 | GO:0015421 | oligopeptide-transporting ATPase activity(GO:0015421) |
0.2 | 3.2 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.2 | 0.3 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.2 | 0.5 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.2 | 0.8 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.2 | 0.3 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.2 | 1.2 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.2 | 1.7 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.2 | 0.5 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.2 | 0.7 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.2 | 8.7 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.2 | 37.6 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.2 | 0.5 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.2 | 2.3 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.2 | 0.7 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.2 | 0.3 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.2 | 0.2 | GO:0005416 | cation:amino acid symporter activity(GO:0005416) L-proline transmembrane transporter activity(GO:0015193) |
0.2 | 3.2 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.2 | 3.7 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.2 | 0.8 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.2 | 4.0 | GO:0003823 | antigen binding(GO:0003823) |
0.2 | 1.0 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
0.2 | 0.6 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.2 | 2.5 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.2 | 0.6 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.2 | 0.8 | GO:0016307 | phosphatidylinositol phosphate kinase activity(GO:0016307) |
0.2 | 0.2 | GO:0099528 | G-protein coupled neurotransmitter receptor activity(GO:0099528) |
0.2 | 2.3 | GO:0001076 | transcription factor activity, RNA polymerase II transcription factor binding(GO:0001076) |
0.2 | 3.6 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.2 | 0.3 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.2 | 0.5 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.2 | 1.4 | GO:0003924 | GTPase activity(GO:0003924) |
0.1 | 0.4 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 1.9 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 0.3 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.1 | 0.1 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 0.7 | GO:0015923 | mannosidase activity(GO:0015923) |
0.1 | 0.3 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.1 | 0.3 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.1 | 0.4 | GO:0005549 | odorant binding(GO:0005549) |
0.1 | 1.3 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 1.7 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 0.4 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.1 | 0.1 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.1 | 2.4 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.1 | 0.4 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.1 | 0.6 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 0.7 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 5.6 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 0.6 | GO:0051635 | obsolete bacterial cell surface binding(GO:0051635) |
0.1 | 1.8 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.1 | 1.4 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.1 | 0.3 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.1 | 0.4 | GO:0005346 | purine ribonucleotide transmembrane transporter activity(GO:0005346) |
0.1 | 1.1 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.1 | 0.7 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 0.3 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.1 | 0.7 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 1.0 | GO:0015232 | heme transporter activity(GO:0015232) |
0.1 | 0.5 | GO:0004974 | icosanoid receptor activity(GO:0004953) leukotriene receptor activity(GO:0004974) |
0.1 | 0.4 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.1 | 0.3 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.1 | 0.4 | GO:0017069 | snRNA binding(GO:0017069) |
0.1 | 9.8 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.1 | 0.7 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.1 | 0.5 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.1 | 0.1 | GO:0008061 | chitin binding(GO:0008061) |
0.1 | 2.8 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 1.3 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.1 | 0.1 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.1 | 0.3 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.1 | 0.4 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.1 | 64.3 | GO:0003723 | RNA binding(GO:0003723) |
0.1 | 0.1 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.1 | 1.8 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.1 | 219.4 | GO:0003676 | nucleic acid binding(GO:0003676) |
0.1 | 0.6 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 0.3 | GO:0019955 | cytokine binding(GO:0019955) |
0.1 | 0.6 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.1 | 1.1 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.1 | 0.5 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.1 | 1.1 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.1 | 0.7 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.1 | 4.9 | GO:0015370 | solute:sodium symporter activity(GO:0015370) |
0.1 | 0.2 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
0.1 | 1.6 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.1 | 0.2 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 0.4 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.1 | 1.3 | GO:0008483 | transaminase activity(GO:0008483) |
0.1 | 4.6 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) |
0.1 | 2.3 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.1 | 0.8 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.1 | 0.7 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.1 | 0.1 | GO:0016362 | activin receptor activity, type II(GO:0016362) |
0.1 | 0.4 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 0.1 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.1 | 0.5 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.1 | 0.2 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.1 | 0.5 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.1 | 0.9 | GO:0016779 | nucleotidyltransferase activity(GO:0016779) |
0.1 | 0.3 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.1 | 0.3 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.1 | 0.7 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.1 | 2.1 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.1 | 0.6 | GO:0016849 | phosphorus-oxygen lyase activity(GO:0016849) |
0.1 | 11.5 | GO:0004871 | signal transducer activity(GO:0004871) |
0.1 | 0.3 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 1.5 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.1 | 1.8 | GO:0016878 | acid-thiol ligase activity(GO:0016878) |
0.1 | 0.8 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 0.2 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 0.1 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.1 | 0.2 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.1 | 0.3 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 0.2 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 4.1 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.1 | 0.1 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.1 | 1.1 | GO:0030145 | manganese ion binding(GO:0030145) |
0.1 | 0.1 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 0.2 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 0.2 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.1 | 0.3 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 1.1 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.1 | 0.2 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.1 | 0.4 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.1 | 2.7 | GO:0031625 | ubiquitin protein ligase binding(GO:0031625) ubiquitin-like protein ligase binding(GO:0044389) |
0.1 | 1.5 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.1 | 17.3 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.1 | 0.6 | GO:0008493 | tetracycline transporter activity(GO:0008493) |
0.1 | 0.2 | GO:0031420 | potassium ion binding(GO:0030955) alkali metal ion binding(GO:0031420) |
0.1 | 0.8 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.1 | 0.2 | GO:0016595 | glutamate binding(GO:0016595) |
0.1 | 0.3 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.1 | 0.3 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.1 | 0.8 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.1 | 0.4 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.1 | 0.7 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.1 | 0.9 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 0.3 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.1 | 0.1 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.1 | 0.5 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.1 | 26.4 | GO:0019001 | GTP binding(GO:0005525) guanyl nucleotide binding(GO:0019001) guanyl ribonucleotide binding(GO:0032561) |
0.1 | 1.0 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.1 | 0.3 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.1 | 0.1 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.1 | 0.5 | GO:0035240 | dopamine binding(GO:0035240) |
0.1 | 0.8 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
0.1 | 1.0 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.1 | 1.8 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.1 | 5.3 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.1 | 0.1 | GO:0015605 | organophosphate ester transmembrane transporter activity(GO:0015605) |
0.1 | 0.2 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 6.1 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.1 | 0.3 | GO:0004339 | glucan 1,4-alpha-glucosidase activity(GO:0004339) |
0.1 | 0.5 | GO:0005372 | water transmembrane transporter activity(GO:0005372) water channel activity(GO:0015250) |
0.1 | 0.1 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.1 | 0.9 | GO:0071814 | low-density lipoprotein particle binding(GO:0030169) lipoprotein particle binding(GO:0071813) protein-lipid complex binding(GO:0071814) |
0.1 | 3.4 | GO:0003682 | chromatin binding(GO:0003682) |
0.1 | 1.4 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.1 | 1.1 | GO:0061733 | peptide N-acetyltransferase activity(GO:0034212) peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.1 | 1.8 | GO:0016675 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.8 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 0.2 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.1 | 0.4 | GO:0043531 | ADP binding(GO:0043531) |
0.1 | 1.8 | GO:0051540 | iron-sulfur cluster binding(GO:0051536) metal cluster binding(GO:0051540) |
0.1 | 3.0 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.1 | 0.8 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.1 | 0.5 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.1 | 0.4 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 0.2 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.1 | 0.1 | GO:0045502 | dynein binding(GO:0045502) |
0.1 | 0.3 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.1 | 0.2 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.1 | 1.8 | GO:0016875 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.1 | 0.2 | GO:0043515 | kinetochore binding(GO:0043515) |
0.1 | 0.5 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 0.2 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.1 | 0.4 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.1 | 0.1 | GO:0042910 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.1 | 0.1 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
0.1 | 0.6 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.1 | 2.2 | GO:0042625 | ATPase coupled ion transmembrane transporter activity(GO:0042625) |
0.1 | 0.3 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.1 | 0.1 | GO:0004340 | glucokinase activity(GO:0004340) |
0.1 | 0.8 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.1 | GO:0045182 | translation regulator activity(GO:0045182) |
0.1 | 0.1 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.1 | 0.2 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.1 | 0.1 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.1 | 0.1 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.1 | 0.5 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 0.2 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.1 | 0.2 | GO:0004114 | 3',5'-cyclic-nucleotide phosphodiesterase activity(GO:0004114) |
0.1 | 0.6 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.1 | 0.2 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.1 | 4.1 | GO:0008022 | protein C-terminus binding(GO:0008022) |
0.1 | 0.2 | GO:0051184 | cofactor transporter activity(GO:0051184) |
0.1 | 0.5 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.1 | 5.6 | GO:0005179 | hormone activity(GO:0005179) |
0.1 | 0.2 | GO:0032182 | ubiquitin-like protein binding(GO:0032182) |
0.1 | 8.1 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 0.6 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.1 | 4.8 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 0.3 | GO:0005048 | signal sequence binding(GO:0005048) |
0.1 | 0.4 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.1 | 6.8 | GO:0003774 | motor activity(GO:0003774) |
0.1 | 0.5 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.1 | 2.6 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 1.3 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.1 | 5.8 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.1 | 0.2 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.1 | 0.3 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 0.1 | GO:0016453 | C-acetyltransferase activity(GO:0016453) |
0.1 | 0.2 | GO:0042287 | MHC protein binding(GO:0042287) |
0.1 | 7.2 | GO:0005125 | cytokine activity(GO:0005125) |
0.0 | 0.0 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.0 | 0.2 | GO:0010181 | FMN binding(GO:0010181) |
0.0 | 0.6 | GO:0042393 | histone binding(GO:0042393) |
0.0 | 0.1 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.1 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.0 | 0.2 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 0.1 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.0 | 0.7 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.0 | 0.0 | GO:0033265 | choline binding(GO:0033265) |
0.0 | 1.5 | GO:0015297 | antiporter activity(GO:0015297) |
0.0 | 0.0 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.0 | 21.5 | GO:0008270 | zinc ion binding(GO:0008270) |
0.0 | 0.1 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.0 | 0.7 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.0 | 1.2 | GO:0004553 | hydrolase activity, hydrolyzing O-glycosyl compounds(GO:0004553) |
0.0 | 1.7 | GO:0072509 | divalent inorganic cation transmembrane transporter activity(GO:0072509) |
0.0 | 0.1 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) thiamine pyrophosphate binding(GO:0030976) |
0.0 | 0.4 | GO:0046915 | transition metal ion transmembrane transporter activity(GO:0046915) |
0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 35.9 | GO:0004872 | receptor activity(GO:0004872) molecular transducer activity(GO:0060089) |
0.0 | 0.1 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.0 | 0.9 | GO:0050661 | NADP binding(GO:0050661) |
0.0 | 0.2 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.0 | 0.7 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.0 | 0.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 0.0 | GO:0004396 | hexokinase activity(GO:0004396) |
0.0 | 0.0 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.0 | 0.2 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.7 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.0 | 0.0 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.0 | 0.1 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.0 | 0.1 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.0 | 0.3 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.0 | 0.1 | GO:0016411 | acylglycerol O-acyltransferase activity(GO:0016411) |
0.0 | 0.3 | GO:0016835 | carbon-oxygen lyase activity(GO:0016835) |
0.0 | 0.2 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.0 | 0.5 | GO:0004175 | endopeptidase activity(GO:0004175) |
0.0 | 0.1 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 1.0 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 0.0 | GO:0016151 | nickel cation binding(GO:0016151) |
0.0 | 0.0 | GO:0000149 | SNARE binding(GO:0000149) |
0.0 | 0.0 | GO:1901677 | phosphate transmembrane transporter activity(GO:1901677) |
0.0 | 0.0 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.0 | 0.0 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) phosphatidylinositol 3-kinase activity(GO:0035004) |
0.0 | 0.1 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 0.0 | GO:0016885 | ligase activity, forming carbon-carbon bonds(GO:0016885) |
0.0 | 0.1 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.2 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
0.0 | 0.0 | GO:0016798 | hydrolase activity, acting on glycosyl bonds(GO:0016798) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 2.3 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
1.1 | 73.2 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
1.1 | 12.0 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.8 | 1.6 | PID EPO PATHWAY | EPO signaling pathway |
0.8 | 17.6 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.7 | 4.5 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.7 | 10.7 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.7 | 12.1 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.6 | 18.0 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.6 | 22.7 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.6 | 18.1 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.6 | 14.6 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.6 | 2.2 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.5 | 1.6 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.5 | 9.5 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.5 | 4.7 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.5 | 1.0 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.5 | 5.9 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.5 | 2.4 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.5 | 2.9 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.5 | 2.4 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.5 | 10.9 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.5 | 9.8 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.5 | 10.7 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.5 | 4.1 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.5 | 13.3 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.5 | 12.7 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.4 | 3.1 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.4 | 2.1 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.4 | 6.1 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.4 | 3.9 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.4 | 4.9 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.4 | 2.2 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.4 | 2.9 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.3 | 7.0 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.3 | 6.9 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.3 | 4.4 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.3 | 2.0 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.3 | 1.6 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.3 | 1.6 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.3 | 1.9 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.3 | 1.0 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.3 | 6.4 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.3 | 17.8 | PID P73PATHWAY | p73 transcription factor network |
0.3 | 5.3 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.3 | 5.3 | PID BCR 5PATHWAY | BCR signaling pathway |
0.3 | 0.9 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.3 | 2.7 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.3 | 5.2 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.3 | 10.3 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.3 | 0.3 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.3 | 14.2 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.3 | 1.7 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.3 | 0.3 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.3 | 0.3 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.3 | 0.3 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.3 | 10.3 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.3 | 3.0 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.3 | 2.7 | PID RAS PATHWAY | Regulation of Ras family activation |
0.3 | 4.8 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.3 | 0.8 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.3 | 0.5 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.3 | 1.0 | PID ENDOTHELIN PATHWAY | Endothelins |
0.3 | 1.8 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.2 | 5.2 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.2 | 1.0 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.2 | 1.0 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.2 | 13.2 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.2 | 0.7 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.2 | 2.3 | PID IFNG PATHWAY | IFN-gamma pathway |
0.2 | 2.8 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.2 | 0.7 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.2 | 2.0 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.2 | 0.4 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.2 | 3.1 | PID ARF 3PATHWAY | Arf1 pathway |
0.2 | 6.3 | PID LKB1 PATHWAY | LKB1 signaling events |
0.2 | 7.3 | PID PLK1 PATHWAY | PLK1 signaling events |
0.2 | 3.1 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.2 | 5.5 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.2 | 0.6 | ST GAQ PATHWAY | G alpha q Pathway |
0.2 | 3.1 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.2 | 1.5 | PID MYC PATHWAY | C-MYC pathway |
0.2 | 2.3 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.2 | 0.4 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.2 | 0.4 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.2 | 3.0 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.2 | 1.5 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.2 | 0.2 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.2 | 3.1 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.2 | 10.6 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.2 | 1.6 | PID ALK1 PATHWAY | ALK1 signaling events |
0.2 | 0.8 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.2 | 4.1 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.2 | 2.4 | PID ARF6 PATHWAY | Arf6 signaling events |
0.2 | 0.5 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 3.1 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 4.3 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 3.2 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.1 | 0.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 1.4 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 1.2 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 0.3 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 2.7 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 1.4 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 3.7 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 1.3 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 4.5 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 0.5 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 2.3 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 1.7 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 0.6 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 1.4 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 0.7 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 1.6 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 0.1 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 1.3 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 0.1 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.1 | 2.8 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.1 | 0.3 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 3.1 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 1.3 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 0.3 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 1.4 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 3.3 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 0.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 1.2 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 1.7 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 1.5 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 0.7 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.1 | 1.0 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 0.5 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 0.1 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 1.1 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 0.8 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 1.5 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 0.2 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 0.6 | PID ATM PATHWAY | ATM pathway |
0.1 | 9.9 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.7 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.7 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.3 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 1.0 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.0 | 0.6 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.4 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.8 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 0.2 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.3 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 0.2 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 0.1 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.1 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 0.2 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 6.4 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
1.1 | 12.2 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
1.1 | 31.5 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
1.1 | 2.1 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
1.0 | 4.0 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.9 | 20.9 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.9 | 0.9 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
0.9 | 10.1 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.9 | 22.4 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.8 | 0.8 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
0.8 | 3.8 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.7 | 2.2 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.7 | 6.3 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.7 | 0.7 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.7 | 6.7 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.6 | 8.9 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.6 | 2.4 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.6 | 0.6 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.6 | 4.7 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.6 | 1.7 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.6 | 5.5 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.5 | 0.5 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.5 | 6.0 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.5 | 19.0 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.5 | 8.9 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.5 | 4.9 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.5 | 7.8 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.5 | 2.4 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.5 | 1.0 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.5 | 0.5 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.5 | 2.4 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
0.5 | 0.5 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.5 | 0.9 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.5 | 4.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.5 | 2.7 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.5 | 0.5 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.5 | 3.2 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.5 | 0.9 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.4 | 10.2 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.4 | 5.3 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.4 | 9.7 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.4 | 0.4 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.4 | 24.0 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.4 | 6.9 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.4 | 3.0 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.4 | 7.2 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.4 | 7.0 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.4 | 11.3 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.4 | 22.0 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.4 | 10.6 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.4 | 10.2 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.4 | 1.2 | REACTOME G PROTEIN BETA GAMMA SIGNALLING | Genes involved in G-protein beta:gamma signalling |
0.4 | 1.9 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.4 | 6.1 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.4 | 7.5 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.4 | 3.4 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.4 | 4.8 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.4 | 2.6 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.4 | 2.5 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.4 | 4.3 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.3 | 8.0 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.3 | 2.8 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.3 | 6.2 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.3 | 0.3 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.3 | 2.0 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.3 | 3.0 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.3 | 1.0 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.3 | 5.2 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.3 | 6.2 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.3 | 6.5 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.3 | 0.6 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.3 | 7.0 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.3 | 11.6 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.3 | 2.5 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.3 | 0.3 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.3 | 0.9 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.3 | 2.6 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.3 | 0.3 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.3 | 4.5 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.3 | 4.8 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.3 | 6.7 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.3 | 4.2 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
0.3 | 0.6 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.3 | 1.7 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.3 | 1.1 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.3 | 3.8 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.3 | 1.9 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.3 | 2.5 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.3 | 4.1 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.3 | 4.1 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.3 | 4.9 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.3 | 4.9 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.3 | 3.8 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.3 | 2.4 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.3 | 0.5 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.3 | 2.9 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.3 | 12.8 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.3 | 0.8 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.3 | 2.8 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.2 | 3.7 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.2 | 0.2 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.2 | 18.8 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.2 | 3.4 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.2 | 0.7 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.2 | 7.2 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.2 | 0.7 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.2 | 0.9 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.2 | 0.2 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.2 | 3.0 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.2 | 4.1 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.2 | 3.0 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.2 | 2.7 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS | Genes involved in CREB phosphorylation through the activation of Ras |
0.2 | 0.2 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.2 | 2.0 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.2 | 0.4 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.2 | 0.6 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.2 | 18.1 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.2 | 3.7 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.2 | 3.4 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
0.2 | 1.7 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.2 | 0.2 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.2 | 1.7 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.2 | 10.3 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.2 | 0.8 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.2 | 8.2 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.2 | 4.0 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.2 | 2.0 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.2 | 2.1 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.2 | 2.1 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.2 | 1.1 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.2 | 0.2 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.2 | 3.2 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.2 | 0.4 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.2 | 3.5 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.2 | 0.6 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.2 | 2.8 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.2 | 4.8 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.2 | 2.2 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.2 | 1.8 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.2 | 1.4 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.2 | 1.3 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.2 | 2.3 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.2 | 2.0 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.2 | 0.7 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.2 | 0.4 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.2 | 2.6 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.2 | 1.8 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.2 | 2.8 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.2 | 0.3 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.2 | 1.5 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.2 | 10.0 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.2 | 0.8 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.2 | 1.2 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.2 | 3.7 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.2 | 11.3 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.2 | 1.8 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.2 | 2.5 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
0.2 | 3.4 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.2 | 6.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.2 | 2.3 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.2 | 2.6 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.2 | 2.7 | REACTOME TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT | Genes involved in The citric acid (TCA) cycle and respiratory electron transport |
0.2 | 3.9 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.2 | 0.2 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.2 | 5.0 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.2 | 5.9 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.2 | 2.0 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.2 | 0.8 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.2 | 9.8 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.2 | 0.3 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 6.4 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 1.9 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 2.9 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
0.1 | 2.2 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 1.4 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 3.9 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 3.0 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.1 | 1.4 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.1 | 6.6 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.1 | 0.7 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.1 | 0.1 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
0.1 | 2.0 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 15.7 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 1.1 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.1 | 36.7 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.1 | 2.0 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.1 | 0.7 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.1 | 1.2 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 2.5 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 1.2 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 3.5 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.1 | 7.5 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 4.5 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.1 | 2.6 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 1.6 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 1.7 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.1 | 1.7 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.1 | 5.1 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.1 | 1.3 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 0.9 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 3.8 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 4.3 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 3.1 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.1 | 1.2 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.1 | 5.5 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.1 | 0.7 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 0.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 0.5 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.1 | 1.0 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 1.1 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 2.2 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 1.0 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 0.9 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.1 | 1.5 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
0.1 | 1.2 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 0.4 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.1 | 0.5 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.1 | 1.2 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 0.5 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 0.8 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 1.9 | REACTOME MITOTIC G2 G2 M PHASES | Genes involved in Mitotic G2-G2/M phases |
0.1 | 0.3 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 2.2 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 0.3 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.1 | 0.9 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 5.1 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 0.4 | REACTOME POST TRANSLATIONAL PROTEIN MODIFICATION | Genes involved in Post-translational protein modification |
0.0 | 0.6 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.0 | 2.8 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.0 | 0.9 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.0 | 0.1 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.0 | 2.2 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 3.2 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.0 | 0.3 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 0.4 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 0.4 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.0 | 0.7 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 0.1 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.0 | 0.2 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.3 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.0 | 0.2 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.0 | 0.1 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.0 | 0.1 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.1 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.0 | 0.4 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 4.5 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |